Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection

1.

(CHMP) CfMPfHU (2010) Guideline on missing data in confirmatory clinical trials. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/09/WC500096793.pdf. Accessed 6 Aug 2018

2.

Abas L, Bogoyevitch MA, Guppy M (2000) Mitochondrial ATP production is necessary for activation of the extracellular-signal-regulated kinases during ischaemia/reperfusion in rat myocyte-derived H9c2 cells. Biochem J 349:119–126PubMedPubMedCentralCrossRef

3.

Abogresha NM, Greish SM, Abdelaziz EZ, Khalil WF (2016) Remote effect of kidney ischemia-reperfusion injury on pancreas: role of oxidative stress and mitochondrial apoptosis. Arch Med Sci 12:252–262. https://doi.org/10.5114/aoms.2015.48130 PubMedCrossRef

4.

Ackers-Johnson M, Li PY, Holmes AP, O’Brien SM, Pavlovic D, Foo RS (2016) A simplified, Langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart. Circ Res 119:909–920. https://doi.org/10.1161/CIRCRESAHA.116.309202 PubMedPubMedCentralCrossRef

5.

Adameova A, Goncalvesova E, Szobi A, Dhalla NS (2016) Necroptotic cell death in failing heart: relevance and proposed mechanisms. Heart Fail Rev 21:213–221. https://doi.org/10.1007/s10741-016-9537-8 PubMedCrossRef

6.

Adelborg K, Horvath-Puho E, Schmidt M, Munch T, Pedersen L, Nielsen PH, Botker HE, Toft Sorensen H (2017) Thirty-year mortality after coronary artery bypass graft surgery: a Danish nationwide population-based cohort study. Circ Cardiovasc Qual Outcomes 10:e002708. https://doi.org/10.1161/CIRCOUTCOMES.116.002708 PubMedCrossRef

7.

Agg B, Baranyai T, Makkos A, Veto B, Farago N, Zvara A, Giricz Z, Veres DV, Csermely P, Aranyi T, Puskas LG, Varga ZV, Ferdinandy P (2018) MicroRNA interactome analysis predicts post-transcriptional regulation of ADRB2 and PPP3R1 in the hypercholesterolemic myocardium. Sci Rep 8:10134. https://doi.org/10.1038/s41598-018-27740-3 PubMedPubMedCentralCrossRef

8.

Aguero J, Galan-Arriola C, Fernandez-Jimenez R, Sanchez-Gonzalez J, Ajmone N, Delgado V, Solis J, Lopez GJ, de Molina-Iracheta A, Hajjar RJ, Bax JJ, Fuster V, Ibanez B (2017) Atrial infarction and ischemic mitral regurgitation contribute to post-MI remodeling of the feft atrium. J Am Coll Cardiol 70:2878–2889. https://doi.org/10.1016/j.jacc.2017.10.013 PubMedCrossRef

9.

Ahn D, Cheng L, Moon C, Spurgeon H, Lakatta EG, Talan MI (2004) Induction of myocardial infarcts of a predictable size and location by branch pattern probability-assisted coronary ligation in C57BL/6 mice. Am J Physiol Heart Circ Physiol 286:H1201–H1207. https://doi.org/10.1152/ajpheart.00862.2003 PubMedCrossRef

10.

Aksentijevic D, Lewis HR, Shattock MJ (2016) Is rate-pressure product of any use in the isolated rat heart? Assessing cardiac ‘effort’ and oxygen consumption in the Langendorff-perfused heart. Exp Physiol 101:282–294. https://doi.org/10.1113/EP085380 PubMedCrossRef

11.

Albrecht SC, Barata AG, Grosshans J, Teleman AA, Dick TP (2011) In vivo mapping of hydrogen peroxide and oxidized glutathione reveals chemical and regional specificity of redox homeostasis. Cell Metab 14:819–829. https://doi.org/10.1016/j.cmet.2011.10.010 PubMedCrossRef

12.

Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr, Arai AE (2006) Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 113:1865–1870. https://doi.org/10.1161/CIRCULATIONAHA.105.576025 PubMedCrossRef

13.

Allshire A, Piper HM, Cuthbertson KSR, Cobbold PH (1987) Cytosolic free calcium in single rat heart cells during anoxia and reoxygenation. Biochem J 244:381–385PubMedPubMedCentralCrossRef

14.

Altschuld RA, Wenger WC, Lamka KG, Kindig OR, Capen CC, Mizuhira V, Vander Heide RS, Brierley GP (1985) Structural and functional properties of adult rat heart myocytes lysed with digitonin. J Biol Chem 260:14325–14334PubMed

15.

Andreadou I, Bibli SI, Mastromanolis E, Zoga A, Efentakis P, Papaioannou N, Farmakis D, Kremastinos DT, Iliodromitis EK (2015) Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: insights into intracellular signaling. Int J Cardiol 184:140–151. https://doi.org/10.1016/j.ijcard.2015.01.079 PubMedCrossRef

16.

Andreadou I, Efentakis P, Balafas E, Togliatto G, Davos CH, Varela A, Dimitriou CA, Nikolaou PE, Maratou E, Lambadiari V, Ikonomidis I, Kostomitsopoulos N, Brizzi MF, Dimitriadis G, Iliodromitis EK (2017) Empagliflozin limits myocardial infarction in vivo and cell death in vitro: role of STAT3, mitochondria, and redox aspects. Front Physiol 8:1077. https://doi.org/10.3389/fphys.2017.01077 PubMedPubMedCentralCrossRef

17.

Andreadou I, Farmakis D, Prokovas E, Sigala F, Zoga A, Spyridaki K, Papalois A, Papapetropoulos A, Anastasiou-Nana M, Kremastinos DT, Iliodromitis EK (2012) Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress. Cardiovasc Res 94:501–509. https://doi.org/10.1093/cvr/cvs121 PubMedCrossRef

18.

Andreadou I, Iliodromitis EK, Tsovolas K, Aggeli IK, Zoga A, Gaitanaki C, Paraskevaidis IA, Markantonis SL, Beis I, Kremastinos DT (2006) Acute administration of vitamin E triggers preconditioning via K(ATP) channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radic Biol Med 41:1092–1099. https://doi.org/10.1016/j.freeradbiomed.2006.06.021 PubMedCrossRef

19.

Antoniel M, Jones K, Antonucci S, Spolaore B, Fogolari F, Petronilli V, Giorgio V, Carraro M, Di Lisa F, Forte M, Szabo I, Lippe G, Bernardi P (2017) The unique histidine in OSCP subunit of F-ATP synthase mediates inhibition of the permeability transition pore by acidic pH. EMBO Rep. https://doi.org/10.15252/embr.201744705 PubMedCrossRefPubMedCentral

20.

Argaud L, Rioufol G, Lievre M, Bontemps L, Legalery P, Stumpf M, Finet G, Itti R, Andre-Fouet X, Ovize M (2004) Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk. Eur Heart J 25:2019–2025. https://doi.org/10.1016/j.ehj.2004.07.040 PubMedCrossRef

21.

Armstrong SC, Ganote CE (1994) Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischaemia. Cardiovasc Res 28:1700–1706PubMedCrossRef

22.

Armstrong SC, Liu GS, Downey JM, Ganote CE (1995) Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J Mol Cell Cardiol 27:1765–1774PubMedCrossRef

23.

Asfour H, Wengrowski AM, Jaimes R 3rd, Swift LM, Kay MW (2012) NADH fluorescence imaging of isolated biventricular working rabbit hearts. J Vis Exp 65:e4115. https://doi.org/10.3791/4115 CrossRef

24.

Avkiran M, Curtis MJ (1991) Independent dual perfusion of left and right coronary arteries in isolated rat hearts. Am J Physiol 261:H2082–H2090PubMed

25.

Azhar G, Gao W, Liu L, Wei JY (1999) Ischemia-reperfusion in the adult mouse heart influence of age. Exp Gerontol 34:699–714PubMedCrossRef

26.

Azuaje FJ, Dewey FE, Brutsaert DL, Devaux Y, Ashley EA, Wagner DR (2012) Systems-based approaches to cardiovascular biomarker discovery. Circ Cardiovasc Genet 5:360–367. https://doi.org/10.1161/CIRCGENETICS.112.962977 PubMedCrossRef

27.

Baars T, Skyschally A, Klein-Hitpass L, Cario E, Erbel R, Heusch G, Kleinbongard P (2014) microRNA expression and its potential role in cardioprotection by ischemic postconditioning in pigs. Pflügers Arch Eur J Physiol 466:1953–1961. https://doi.org/10.1007/s00424-013-1429-3 CrossRef

28.

Baker JE, Konorev EA, Gross GJ, Chilian WM, Jacob HJ (2000) Resistance to myocardial ischemia in five rat strains: is there a genetic component of cardioprotection? Am J Physiol Heart Circ Physiol 278:H1395–H1400. https://doi.org/10.1152/ajpheart.2000.278.4.H1395 PubMedCrossRef

29.

Baranyai T, Giricz Z, Varga ZV, Koncsos G, Lukovic D, Makkos A, Sarkozy M, Pavo N, Jakab A, Czimbalmos C, Vago H, Ruzsa Z, Toth L, Garamvolgyi R, Merkely B, Schulz R, Gyongyosi M, Ferdinandy P (2017) In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature. J Transl Med 15:67. https://doi.org/10.1186/s12967-017-1166-z PubMedPubMedCentralCrossRef

30.

Barrabés JA, Garcia-Dorado D, Ruiz-Meana M, Piper HM, Solares J, González MA, Oliveras J, Herrejon MP, Soler Soler J (1996) Myocardial segment shrinkage during coronary reperfusion in situ. Relation to hypercontracture and myocardial necrosis. Pflügers Arch 431:519–526PubMedCrossRef

31.

Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, Bernardi P (2005) Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem 280:18558–18561. https://doi.org/10.1074/jbc.C500089200 PubMedCrossRef

32.

Bautin AE, Galagudza MM, Datsenko SV, Tashkhanov DM, Marichev AO, Bakanov A, Malaia E, Naimushin AV, Rubinchik VE, Gordeev ML (2014) Effects of remote ischemic preconditioning on perioperative period in elective aortic valve replacement. Anesteziol Reanimatol 3:11–17

33.

Bayat H, Swaney JS, Ander AN, Dalton N, Kennedy BP, Hammond HK, Roth DM (2002) Progressive heart failure after myocardial infarction in mice. Basic Res Cardiol 97:206–213PubMedCrossRef

34.

Behmenburg F, Boekholt Y, van Caster P, Dorsch M, Heinen A, Hollmann MW, Huhn R (2017) Extended second window of protection of sevoflurane-induced preconditioning. J Cardiovasc Pharmacol 70:284–289. https://doi.org/10.1097/FJC.0000000000000517 PubMedCrossRef

35.

Bell RM, Mocanu MM, Yellon DM (2011) Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol 50:940–950. https://doi.org/10.1016/j.yjmcc.2011.02.018 PubMedCrossRef

36.

Belousov VV, Fradkov AF, Lukyanov KA, Staroverov DB, Shakhbazov KS, Terskikh AV, Lukyanov S (2006) Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. Nat Methods 3:281–286. https://doi.org/10.1038/nmeth866 PubMedCrossRef

37.

Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98–102. https://doi.org/10.1126/science.1164680 PubMedPubMedCentralCrossRef

38.

Bergmann R, Ludbrook J, Spooren WPJM (2000) Different outcomes of the Wilcoxon–Mann–Whitney test from different statistics packages. Am Statist 54:72–77. https://doi.org/10.1080/00031305.2000.10474513 CrossRef

39.

Bernardi P, Di Lisa F (2015) The mitochondrial permeability transition pore: Molecular nature and role as a target in cardioprotection. J Mol Cell Cardiol 78c:100–106. https://doi.org/10.1016/j.yjmcc.2014.09.023 CrossRef

40.

Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F (1999) Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem 264:687–701PubMedCrossRef

41.

Berridge MV, Tan AS (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303:474–482. https://doi.org/10.1006/abbi.1993.1311 PubMedCrossRef

42.

Beyers RJ, Smith RS, Xu Y, Piras BA, Salerno M, Berr SS, Meyer CH, Kramer CM, French BA, Epstein FH (2012) T(2) -weighted MRI of post-infarct myocardial edema in mice. Magn Reson Med 67:201–209. https://doi.org/10.1002/mrm.22975 PubMedCrossRef

43.

Bibli SI, Andreadou I, Chatzianastasiou A, Tzimas C, Sanoudou D, Kranias E, Brouckaert P, Coletta C, Szabo C, Kremastinos DT, Iliodromitis EK, Papapetropoulos A (2015) Cardioprotection by H₂S engages a cGMP-dependent protein kinase G/phospholamban pathway. Cardiovasc Res 106:432–442. https://doi.org/10.1093/cvr/cvv129 PubMedPubMedCentralCrossRef

44.

Bilan DS, Belousov VV (2016) HyPer family probes: state of the art. Antioxid Redox Signal 24:731–751. https://doi.org/10.1089/ars.2015.6586 PubMedCrossRef

45.

Birket MJ, Mummery CL (2015) Pluripotent stem cell derived cardiovascular progenitors–a developmental perspective. Dev Biol 400:169–179. https://doi.org/10.1016/j.ydbio.2015.01.012 PubMedCrossRef

46.

Birnbaum Y, Hale SL, Kloner RA (1997) Differences in reperfusion length following thirty min of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining. J Mol Cell Cardiol 29:657–666. https://doi.org/10.1006/jmcc.1996.0308 PubMedCrossRef

47.

Blenck CL, Harvey PA, Reckelhoff JF, Leinwand LA (2016) The importance of biological sex and estrogen in rodent models of cardiovascular health and disease. Circ Res 118:1294–1312. https://doi.org/10.1161/CIRCRESAHA.116.307509 PubMedPubMedCentralCrossRef

48.

Boengler K, Bencsik P, Paloczi J, Kiss K, Pipicz M, Pipis J, Ferdinandy P, Schluter KD, Schulz R (2017) Lack of contribution of p66shc and its mitochondrial translocation to ischemia-reperfusion injury and cardioprotection by ischemic preconditioning. Front Physiol 8:733. https://doi.org/10.3389/fphys.2017.00733 PubMedPubMedCentralCrossRef

49.

Boengler K, Konietzka I, Buechert A, Heinen Y, Garcia-Dorado D, Heusch G, Schulz R (2007) Loss of ischemic preconditioning’s cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am J Physiol Heart Circ Physiol 292:H1764–H1769. https://doi.org/10.1152/ajpheart.01071.2006 PubMedCrossRef

50.

Boengler K, Ruiz-Meana M, Gent S, Ungefug E, Soetkamp D, Miro-Casas E, Cabestrero A, Fernandez-Sanz C, Semenzato M, Lisa FD, Rohrbach S, Garcia-Dorado D, Heusch G, Schulz R, Mercola M (2012) Mitochondrial connexin 43 impacts on respiratory complex I activity and mitochondrial oxygen consumption. J Cell Mol Med 16:1649–1655. https://doi.org/10.1111/j.1582-4934.2011.01516.x PubMedPubMedCentralCrossRef

51.

Boengler K, Schulz R, Heusch G (2009) Loss of cardioprotection with ageing. Cardiovasc Res 83:247–261. https://doi.org/10.1093/cvr/cvp033 PubMedCrossRef

52.

Boengler K, Stahlhofen S, van de Sand A, Gres P, Ruiz-Meana M, Garcia-Dorado D, Heusch G, Schulz R (2009) Presence of connexin 43 in subsarcolemmal but not in interfibrillar cardiomyocyte mitochondria. Basic Res Cardiol 104:141–147. https://doi.org/10.1007/s00395-009-0007-5 PubMedCrossRef

53.

Boileau A, Lino Cardenas CL, Lindsay ME, Devaux Y, Cardiolinc N (2018) Endogenous heparin interferes with quantification of microRNAs by RT-qPCR. Clin Chem 64:863–865. https://doi.org/10.1373/clinchem.2017.284653 PubMedCrossRef

54.

Bolli R (2017) New initiatives to improve the rigor and reproducibility of articles published in Circulation Research. Circ Res 121:472–479. https://doi.org/10.1161/CIRCRESAHA.117.311678 PubMedCrossRef

55.

Borst O, Ochmann C, Schonberger T, Jacoby C, Stellos K, Seizer P, Flogel U, Lang F, Gawaz M (2011) Methods employed for induction and analysis of experimental myocardial infarction in mice. Cell Physiol Biochem 28:1–12. https://doi.org/10.1159/000331708 PubMedCrossRef

56.

Bøtker HE (2015) Mitochondrial care in acute myocardial infarction. Eur Heart J 36:77–79. https://doi.org/10.1093/eurheartj/ehu380 PubMedCrossRef

57.

Bøtker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sorensen HT, Redington AN, Nielsen TT (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375:727–734. https://doi.org/10.1016/S0140-6736(09)62001-8 PubMedCrossRef

58.

Bøtker HE, Lassen TR, Jespersen NR (2018) Clinical translation of myocardial conditioning. Am J Physiol Heart Circ Physiol 314:H1225–H1252. https://doi.org/10.1152/ajpheart.00027.2018 PubMedCrossRef

59.

Branco AF, Pereira SP, Gonzalez S, Gusev O, Rizvanov AA, Oliveira PJ (2015) Gene expression profiling of H9c2 myoblast differentiation towards a cardiac-like phenotype. PLoS One 10:e0129303. https://doi.org/10.1371/journal.pone.0129303 PubMedPubMedCentralCrossRef

60.

Breuckmann F, Moehlenkamp S, Nassenstein K, Lehmann N, Ladd S, Schmermund A, Sievers B, Schlosser T, Jockel KH, Heusch G, Erbel R, Barkhausen J (2009) Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology 251:50–57. https://doi.org/10.1148/radiol.2511081118 PubMedCrossRef

61.

Bromage DI, Pickard JM, Rossello X, Ziff OJ, Burke N, Yellon DM, Davidson SM (2017) Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis. Cardiovasc Res 113:288–297. https://doi.org/10.1093/cvr/cvw219 PubMedCrossRef

62.

Bulluck H, Dharmakumar R, Arai AE, Berry C, Hausenloy DJ (2018) Cardiovascular magnetic resonance in acute ST-segment-elevation myocardial infarction: recent advances, controversies, and future directions. Circulation 137:1949–1964. https://doi.org/10.1161/CIRCULATIONAHA.117.030693 PubMedCrossRefPubMedCentral

63.

Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, Anderson JL, Yusuf S (2002) The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 39:30–36. https://doi.org/10.1016/S0735-1097(01)01711-9 PubMedCrossRef

64.

Camacho P, Fan H, Liu Z, He JQ (2016) Small mammalian animal models of heart disease. Am J Cardiovasc Dis 6:70–80PubMedPubMedCentral

65.

Carpi A, Menabo R, Kaludercic N, Pelicci P, Di LF, Giorgio M (2009) The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. Biochim Biophys Acta 1787:744–780. https://doi.org/10.1016/j.bbabio.2009.04.001 CrossRef

66.

Cartledge JE, Kane C, Dias P, Tesfom M, Clarke L, McKee B, Al Ayoubi S, Chester A, Yacoub MH, Camelliti P, Terracciano CM (2015) Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators. Cardiovasc Res 105:260–270. https://doi.org/10.1093/cvr/cvu264 PubMedCrossRef

67.

Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111–1115PubMedCrossRef

68.

Cereghetti GM, Stangherlin A, de Martins BO, Chang CR, Blackstone C, Bernardi P, Scorrano L (2008) Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci USA 105:15803–15808. https://doi.org/10.1073/pnas.0808249105 PubMedCrossRefPubMedCentral

69.

Chen Q, Hoppel CL, Lesnefsky EJ (2006) Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria. J Pharmacol Exp Ther 316:200–207. https://doi.org/10.1124/jpet.105.091702 PubMedCrossRef

70.

Chen Y, Csordas G, Jowdy C, Schneider TG, Csordas N, Wang W, Liu Y, Kohlhaas M, Meiser M, Bergem S, Nerbonne JM, Dorn GW 2nd, Maack C (2012) Mitofusin 2-containing mitochondrial-reticular microdomains direct rapid cardiomyocyte bioenergetic responses via interorganelle Ca(2+) crosstalk. Circ Res 111:863–875. https://doi.org/10.1161/CIRCRESAHA.112.266585 PubMedPubMedCentralCrossRef

71.

Chen YF, Redetzke RA, Sivertson RM, Coburn TS, Cypher LR, Gerdes AM (2011) Post-myocardial infarction left ventricular myocyte remodeling: are there gender differences in rats? Cardiovasc Pathol 20:e189–e195. https://doi.org/10.1016/j.carpath.2010.09.007 PubMedCrossRef

72.

Cheng J, Nanayakkara G, Shao Y, Cueto R, Wang L, Yang WY, Tian Y, Wang H, Yang X (2017) Mitochondrial proton leak plays a critical role in pathogenesis of cardiovascular diseases. Adv Exp Med Biol 982:359–370. https://doi.org/10.1007/978-3-319-55330-6_20 PubMedPubMedCentralCrossRef

73.

Cheng S, Shah SH, Corwin EJ, Fiehn O, Fitzgerald RL, Gerszten RE, Illig T, Rhee EP, Srinivas PR, Wang TJ, Jain M, American Heart Association Council on Functional G, Translational B, Council on C, Stroke N, Council on Clinical C, Stroke C (2017) Potential impact and study considerations of metabolomics in cardiovascular health and disease: a scientific statement from the American Heart Association. Circ Cardiovasc Genet 10:e000032. https://doi.org/10.1161/hcg.0000000000000032 PubMedPubMedCentralCrossRef

74.

Chiari P, Angoulvant D, Mewton N, Desebbe O, Obadia JF, Robin J, Farhat F, Jegaden O, Bastien O, Lehot JJ, Ovize M (2014) Cyclosporine protects the heart during aortic valve surgery. Anesthesiology 121:232–238. https://doi.org/10.1097/ALN.0000000000000331 PubMedCrossRef

75.

Chien GL, Wolff RA, Davis RF, van Winkle DM (1994) “Normothermic range” temperature affects myocardial infarct size. Cardiovasc Res 28:1014–1017PubMedCrossRef

76.

Chinchoy E, Soule CL, Houlton AJ, Gallagher WJ, Hjelle MA, Laske TG, Morissette J, Iaizzo PA (2000) Isolated four-chamber working swine heart model. Ann Thorac Surg 70:1607–1614. https://doi.org/10.1016/S0003-4975(00)01977-9 PubMedCrossRef

77.

Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, Ibacache M, Criollo A, Nemchenko A, Hill JA, Lavandero S (2011) Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 2:e244. https://doi.org/10.1038/cddis.2011.130 PubMedPubMedCentralCrossRef

78.

Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137:1112–1123. https://doi.org/10.1016/j.cell.2009.05.037 PubMedPubMedCentralCrossRef

79.

Choi H, Kim S, Mukhopadhyay P, Cho S, Woo J, Storz G, Ryu SE (2001) Structural basis of the redox switch in the OxyR transcription factor. Cell 105:103–113. https://doi.org/10.1016/S0092-8674(01)00300-2 PubMedCrossRef

80.

Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, James AM, Cocheme HM, Reinhold J, Lilley KS, Partridge L, Fearnley IM, Robinson AJ, Hartley RC, Smith RA, Krieg T, Brookes PS, Murphy MP (2013) Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med 19:753–759. https://doi.org/10.1038/nm.3212 PubMedPubMedCentralCrossRef

81.

Ciuffreda MC, Tolva V, Casana R, Gnecchi M, Vanoli E, Spazzolini C, Roughan J, Calvillo L (2014) Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain. PLoS One 9:e95913. https://doi.org/10.1371/journal.pone.0095913 PubMedPubMedCentralCrossRef

82.

Clarke SJ, McStay GP, Halestrap AP (2002) Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J Biol Chem 277:34793–34799. https://doi.org/10.1074/jbc.M202191200 PubMedCrossRef

83.

Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ Jr (1998) HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95:2979–2984PubMedCrossRefPubMedCentral

84.

Cocheme HM, Logan A, Prime TA, Abakumova I, Quin C, McQuaker SJ, Patel JV, Fearnley IM, James AM, Porteous CM, Smith RA, Hartley RC, Partridge L, Murphy MP (2012) Using the mitochondria-targeted ratiometric mass spectrometry probe MitoB to measure H2O2 in living Drosophila. Nat Protoc 7:946–958. https://doi.org/10.1038/nprot.2012.035 PubMedCrossRef

85.

Cohen MV, Downey JM (2017) The impact of irreproducibility and competing protection from P2Y12 antagonists on the discovery of cardioprotective interventions. Basic Res Cardiol 112:64. https://doi.org/10.1007/s00395-017-0653-y PubMedCrossRef

86.

Cohen MV, Yang X-M, Liu GS, Heusch G, Downey JM (2001) Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K_ATP channels. Circ Res 89:273–278PubMedCrossRef

87.

Corcoran D, Young R, Cialdella P, McCartney P, Bajrangee A, Collison D, Carrick D, Shaukat A, Watkins S, McEntegart M, Watt J, Welsh P, Sattar N, McConnachie A, Oldroyd KG, Berry C (2018) The effects of remote ischaemic pre-conditioning on coronary artery function in patients with stable coronary artery disease. Int J Cardiol 252:24–30. https://doi.org/10.1016/j.ijcard.2017.10.082 PubMedPubMedCentralCrossRef

88.

Cottet-Rousselle C, Ronot X, Leverve X, Mayol JF (2011) Cytometric assessment of mitochondria using fluorescent probes. Cytometry A 79:405–425. https://doi.org/10.1002/cyto.a.21061 PubMedCrossRef

89.

Croisille P, Kim HW, Kim RJ (2012) Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. Radiology 265:12–22. https://doi.org/10.1148/radiol.12111769 PubMedCrossRef

90.

Cullen LA, Mills NL, Mahler S, Body R (2017) Early rule-out and rule-in strategies for myocardial infarction. Clin Chem 63:129–139. https://doi.org/10.1373/clinchem.2016.254730 PubMedCrossRef

91.

Cummings BS, Schnellmann RG (2004) Measurement of cell death in mammalian cells. Curr Protoc Pharmacol Chapter 12: Unit 12 8 https://doi.org/10.1002/0471141755.ph1208s25

92.

Dabkowski ER, Williamson CL, Bukowski VC, Chapman RS, Leonard SS, Peer CJ, Callery PS, Hollander JM (2009) Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations. Am J Physiol Heart Circ Physiol 296:H359–H369. https://doi.org/10.1152/ajpheart.00467.2008 PubMedCrossRef

93.

Dai W, Herring MJ, Hale SL, Kloner RA (2015) Rapid surface cooling by thermosuit system dramatically reduces scar size, prevents post-infarction adverse left ventricular remodeling, and improves cardiac function in rats. J Am Heart Assoc 4:e002265. https://doi.org/10.1161/JAHA.115.002265 PubMedPubMedCentralCrossRef

94.

Danos O, Davies K, Lehn P, Mulligan R (2010) The ARRIVE guidelines, a welcome improvement to standards for reporting animal research. J Gene Med 12:559–560. https://doi.org/10.1002/jgm.1472 PubMedCrossRef

95.

Darling CE, Jiang R, Maynard M, Whittaker P, Vinten-Johansen J, Przyklenk K (2005) Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol 289:H1618–H1626. https://doi.org/10.1152/ajpheart.00055.2005 PubMedCrossRef

96.

de Leiris J, Harding DP, Pestre S (1984) The isolated perfused rat heart: a model for studying myocardial hypoxia or ischaemia. Basic Res Cardiol 79:313–321PubMedCrossRef

97.

De Windt LJ, Willems J, Reneman RS, Van der Vusse GJ, Arts T, Van Bilsen M (1999) An improved isolated, left ventricular ejecting, murine heart model. Functional and metabolic evaluation. Pflugers Arch 437:182–190. https://doi.org/10.1007/s004240050767 PubMedCrossRef

98.

Degabriele NM, Griesenbach U, Sato K, Post MJ, Zhu J, Williams J, Jeffery PK, Geddes DM, Alton EW (2004) Critical appraisal of the mouse model of myocardial infarction. Exp Physiol 89:497–505. https://doi.org/10.1113/expphysiol.2004.027276 PubMedCrossRef

99.

Deja MA, Golba KS, Malinowski M, Widenka K, Biernat J, Szurlej D, Wos S (2006) Diazoxide provides maximal KATP channels independent protection if present throughout hypoxia. Ann Thorac Surg 81:1408–1416. https://doi.org/10.1016/j.athoracsur.2005.11.045 PubMedCrossRef

100.

Delcarpio JB, Lanson NA Jr, Field LJ, Claycomb WC (1991) Morphological characterization of cardiomyocytes isolated from a transplantable cardiac tumor derived from transgenic mouse atria (AT-1 cells). Circ Res 69:1591–1600PubMedCrossRef

101.

Demerouti E, Andreadou I, Aggeli IK, Farmakis D, Zoga A, Gaitanaki C, Beis I, Anastasiou-Nana M, Kremastinos DT, Iliodromitis EK (2013) Ovariectomy reinstates the infarct size-limiting effect of postconditioning in female rabbits. Cell Biochem Biophys 65:373–380. https://doi.org/10.1007/s12013-012-9441-3 PubMedCrossRef

102.

Derumeaux G, Ovize M, Loufoua J, André-Fouet X, Minaire Y, Cribier A, Letac B (1998) Doppler tissue imaging quantitates regional wall motion during myocardial ischemia and reperfusion. Circulation 97:1970–1977PubMedCrossRef

103.

Derumeaux G, Ovize M, Loufoua J, Pontier G, André-Fouet X, Cribier A (2000) Assessment of nonuniformity of transmural myocardial velocities by color-coded tissue doppler imaging. Circulation 101:1390–1395PubMedCrossRef

104.

Devaux Y (2017) Transcriptome of blood cells as a reservoir of cardiovascular biomarkers. Biochim Biophys Acta 1864:209–216. https://doi.org/10.1016/j.bbamcr.2016.11.005 CrossRef

105.

DeWitt ES, Black KJ, Kheir JN (2016) Rodent working heart model for the study of myocardial performance and oxygen consumption. J Vis Exp 114:e45149. https://doi.org/10.3791/54149 CrossRef

106.

Di Lisa F, Fan CZ, Gambassi G, Hogue BA, Kudryashova I, Hansford RG (1993) Altered pyruvate dehydrogenase control and mitochondrial free Ca²⁺ in hearts of cardiomyopathic hamsters. Am J Physiol 264:H2188–H2197. https://doi.org/10.1152/ajpheart.1993.264.6.H2188 PubMedCrossRef

107.

Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P (2001) Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 276:2571–2575. https://doi.org/10.1074/jbc.M006825200 PubMedCrossRef

108.

Di Lisa F, Menabo R, Canton M, Petronilli V (1998) The role of mitochondria in the salvage and the injury of the ischemic myocardium. Biochim Biophys Acta 1366:69–78PubMedCrossRef

109.

Diaz RJ, Wilson GJ (2006) Studying ischemic preconditioning in isolated cardiomyocyte models. Cardiovasc Res 70:286–296. https://doi.org/10.1016/j.cardiores.2005.12.003 PubMedCrossRef

110.

Dikalov SI, Harrison DG (2014) Methods for detection of mitochondrial and cellular reactive oxygen species. Antioxid Redox Signal 20:372–382. https://doi.org/10.1089/ars.2012.4886 PubMedPubMedCentralCrossRef

111.

Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH, Levy JH, Chaitman BR, Broderick S, Mack MJ, Pieper KS, Farkouh ME (2011) Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 305:585–591. https://doi.org/10.1001/jama.2011.99 PubMedCrossRef

112.

Domenech RJ, Hoffman JIE, Noble MIM, Saunders KB, Henson JR, Subijanto S (1969) Total and regional coronary blood flow measured by radioactive microspheres in conscious and anesthetized dogs. Circ Res 25:581–596PubMedCrossRef

113.

Dongworth RK, Campbell-Washburn AE, Cabrera-Fuentes HA, Bulluck H, Roberts T, Price AN, Hernandez-Resendiz S, Ordidge RJ, Thomas DL, Yellon DM, Lythgoe MF, Hausenloy DJ (2017) Quantifying the area-at-risk of myocardial infarction in vivo using arterial spin labeling cardiac magnetic resonance. Sci Rep 7:2271. https://doi.org/10.1038/s41598-017-02544-z PubMedPubMedCentralCrossRef

114.

Dooley CT, Dore TM, Hanson GT, Jackson WC, Remington SJ, Tsien RY (2004) Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J Biol Chem 279:22284–22293. https://doi.org/10.1074/jbc.M312847200 PubMedCrossRef

115.

Dörge H, Neumann T, Behrends M, Skyschally A, Schulz R, Kasper C, Erbel R, Heusch G (2000) Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol 279:H2587–H2592PubMedCrossRef

116.

Dorsch M, Behmenburg F, Raible M, Blase D, Grievink H, Hollmann MW, Heinen A, Huhn R (2016) Morphine-induced preconditioning: involvement of protein kinase A and mitochondrial permeability transition pore. PLoS One 11:e0151025. https://doi.org/10.1371/journal.pone.0151025 PubMedPubMedCentralCrossRef

117.

Du GQ, Xue JY, Guo Y, Chen S, Du P, Wu Y, Wang YH, Zong LQ, Tian JW (2015) Measurement of myocardial perfusion and infarction size using computer-aided diagnosis system for myocardial contrast echocardiography. Ultrasound Med Biol 41:2466–2477. https://doi.org/10.1016/j.ultrasmedbio.2015.04.012 PubMedCrossRef

118.

Duerr GD, Elhafi N, Bostani T, Ellinger J, Swieny L, Kolobara E, Welz A, Dewald O (2011) Comparison of myocardial remodeling between cryoinfarction and reperfused infarction in mice. J Biomed Biotechnol 2011:961298. https://doi.org/10.1155/2011/961298 PubMedCrossRef

119.

Efentakis P, Andreadou I, Bibli SI, Vasileiou S, Dagres N, Zoga A, Lougiakis N, Kremastinos DT, Iliodromitis EK (2016) Ranolazine triggers pharmacological preconditioning and postconditioning in anesthetized rabbits through activation of RISK pathway. Eur J Pharmacol 789:431–438. https://doi.org/10.1016/j.ejphar.2016.08.001 PubMedCrossRef

120.

Efird J (2011) Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health 8:15–20. https://doi.org/10.3390/ijerph8010015 PubMedCrossRef

121.

Ekstrom K, Dalsgaard M, Iversen K, Pedersen-Bjergaard U, Vejlstrup N, Diemar SS, Idorn M, Thorsteinsson B, Engstrom T (2017) Effects of liraglutide and ischemic postconditioning on myocardial salvage after I/R injury in pigs. Scand Cardiovasc J 51:8–14. https://doi.org/10.1080/14017431.2016.1197417 PubMedCrossRef

122.

Elrod JW, Wong R, Mishra S, Vagnozzi RJ, Sakthievel B, Goonasekera SA, Karch J, Gabel S, Farber J, Force T, Heller BJ, Murphy E, Molkentin JD (2010) Cyclophilin D controls mitochondrial pore-dependent Ca²⁺ exchange, metabolic flexibility, and propensity for heart failure in mice. J Clin Invest 120:3680–3687. https://doi.org/10.1172/JCI43171 PubMedPubMedCentralCrossRef

123.

Elz JS, Nayler WG (1988) Calcium gain during postischemic reperfusion. The effect of 2,4-dinitrophenol. Am J Pathol 131:137–145PubMedPubMedCentral

124.

Espe EK, Aronsen JM, Eriksen GS, Zhang L, Smiseth OA, Edvardsen T, Sjaastad I, Eriksen M (2015) Assessment of regional myocardial work in rats. Circ Cardiovasc Imaging 8:e002695. https://doi.org/10.1161/CIRCIMAGING.114.002695 PubMedCrossRef

125.

European Parliament CotEU (2010) Directive 2010/63/EU of the European Parliament and of the council on the protection of animals used for scientific purposes. Off J Euro Union L 276:33–79

126.

Fabris E, Kilic S, Van’t Hof AWJ, Ten Berg J, Ayesta A, Zeymer U, Hamon M, Soulat L, Bernstein D, Anthopoulos P, Deliargyris EN, Steg PG (2017) One-year mortality for bivalirudin vs heparins plus optional glycoprotein IIb/IIIa inhibitor treatment started in the ambulance for ST-segment elevation myocardial infarction: a secondary analysis of the EUROMAX randomized clinical trial. JAMA Cardiol 2:791–796. https://doi.org/10.1001/jamacardio.2016.5975 PubMedPubMedCentralCrossRef

127.

Feng Y, Cona MM, Vunckx K, Li Y, Chen F, Nuyts J, Gheysens O, Zhou L, Xie Y, Oyen R, Ni Y (2013) Detection and quantification of acute reperfused myocardial infarction in rabbits using DISA-SPECT/CT and 3.0T cardiac MRI. Int J Cardiol 168:4191–4198. https://doi.org/10.1016/j.ijcard.2013.07.108 PubMedCrossRef

128.

Feng Y, Xie Y, Wang H, Chen F, Ye Y, Jin L, Marchal G, Ni Y (2009) A modified rabbit model of reperfused myocardial infarction for cardiac MR imaging research. Int J Cardiovasc Imaging 25:289–298. https://doi.org/10.1007/s10554-008-9393-2 PubMedCrossRef

129.

Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R (2014) Interaction of risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 66:1142–1174. https://doi.org/10.1124/pr.113.008300 PubMedCrossRef

130.

Ferdinandy P, Panas D, Schulz R (1999) Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. Am J Physiol 45:H1861–H1867

131.

Fernandez-Jimenez R, Barreiro-Perez M, Martin-Garcia A, Sanchez-Gonzalez J, Aguero J, Galan-Arriola C, Garcia-Prieto J, Diaz-Pelaez E, Vara P, Martinez I, Zamarro I, Garde B, Sanz J, Fuster V, Sanchez PL, Ibanez B (2017) Dynamic edematous response of the human heart to myocardial infarction: implications for assessing myocardial area at risk and salvage. Circulation 136:1288–1300. https://doi.org/10.1161/CIRCULATIONAHA.116.025582 PubMedPubMedCentralCrossRef

132.

Fernandez-Jimenez R, Galan-Arriola C, Sanchez-Gonzalez J, Aguero J, Lopez-Martin GJ, Gomez-Talavera S, Garcia-Prieto J, Benn A, Molina-Iracheta A, Barreiro-Perez M, Martin-Garcia A, Garcia-Lunar I, Pizarro G, Sanz J, Sanchez PL, Fuster V, Ibanez B (2017) Effect of ischemia duration and protective interventions on the temporal dynamics of tissue composition after myocardial infarction. Circ Res 121:439–450. https://doi.org/10.1161/CIRCRESAHA.117.310901 PubMedPubMedCentralCrossRef

133.

Fernandez-Jimenez R, Sanchez-Gonzalez J, Aguero J, Garcia-Prieto J, Lopez-Martin GJ, Garcia-Ruiz JM, Molina-Iracheta A, Rossello X, Fernandez-Friera L, Pizarro G, Garcia-Alvarez A, Dall’Armellina E, Macaya C, Choudhury RP, Fuster V, Ibanez B (2015) Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization. J Am Coll Cardiol 65:315–323. https://doi.org/10.1016/j.jacc.2014.11.004 PubMedCrossRef

134.

Fernandez-Sanz C, Ruiz-Meana M, Castellano J, Miro-Casas E, Nunez E, Inserte J, Vazquez J, Garcia-Dorado D (2015) Altered FoF1 ATP synthase and susceptibility to mitochondrial permeability transition pore during ischaemia and reperfusion in aging cardiomyocytes. Thromb Haemost 113:441–451. https://doi.org/10.1160/TH14-10-0901 PubMedCrossRef

135.

Fernandez-Sanz C, Ruiz-Meana M, Miro-Casas E, Nunez E, Castellano J, Loureiro M, Barba I, Poncelas M, Rodriguez-Sinovas A, Vazquez J, Garcia-Dorado D (2014) Defective sarcoplasmic reticulum-mitochondria calcium exchange in aged mouse myocardium. Cell Death Dis 5:e1573, https://doi.org/10.1038/cddis.2014.526 PubMedPubMedCentralCrossRef

136.

Ferrera R, Benhabbouche S, Bopassa JC, Li B, Ovize M (2009) One hour reperfusion is enough to assess function and infarct size with TTC staining in langendorff rat model. Cardiovasc Drugs Ther 23:327–331. https://doi.org/10.1007/s10557-009-6176-5 PubMedCrossRef

137.

Fidler LM, Wilson GJ, Liu F, Cui X, Scherer SW, Taylor GP, Hamilton RM (2009) Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations. J Cell Mol Med 13:4219–4228. https://doi.org/10.1111/j.1582-4934.2008.00438.x PubMedCrossRef

138.

Fishbein MC, Maclean D, Maroko PR (1978) Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90:57–70PubMedPubMedCentral

139.

Flood A, Hack BD, Headrick JP (2003) Pyruvate-dependent preconditioning and cardioprotection in murine myocardium. Clin Exp Pharmacol Physiol 30:145–152. https://doi.org/10.46/j.1440-1681.2003.03814.x

140.

Fontaine E, Ichas F, Bernardi P (1998) A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J Biol Chem 273:25734–25740PubMedCrossRef

141.

Frezza C, Cipolat S, Scorrano L (2007) Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat Protoc 2:287–295. https://doi.org/10.1038/nprot.2006.478 PubMedCrossRef

142.

Fuentes GC, Newgren J (2008) Physiology and clinical pathology of laboratory New Zealand white rabbits housed individually and in groups. J Am Assoc Lab Anim Sci 47:35–38PubMedPubMedCentral

143.

Fujita M, Morimoto Y, Ishihara M, Shimizu M, Takase B, Maehara T, Kikuchi M (2004) A new rabbit model of myocardial infarction without endotracheal intubation. J Surg Res 116:124–128. https://doi.org/10.1016/S0022-4804(03)00304-4 PubMedCrossRef

144.

Galinanes M, Hearse DJ (1990) Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection. Cardioscience 1:127–143PubMed

145.

Ganote CE, Worstell J, Kaltenbach JP (1976) Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts. Am J Pathol 84:327–350PubMedPubMedCentral

146.

Gao S, Ho D, Vatner DE, Vatner SF (2011) Echocardiography in Mice. Curr Protoc Mouse Biol 1:71–83. https://doi.org/10.1002/9780470942390.mo100130 PubMedPubMedCentralCrossRef

147.

Gao XM, Dart AM, Dewar E, Jennings G, Du XJ (2000) Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovasc Res 45:330–338PubMedCrossRef

148.

Garcia-Dorado D, Inserte J, Ruiz-Meana M, Gonzalez MA, Solares J, Julia M, Barrabés JA, Soler-Soler J (1997) Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 96:3579–3586. https://doi.org/10.1161/01.CIR.96.10.3579 PubMedCrossRef

149.

Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M (2004) Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion. Cardiovasc Res 61:386–401. https://doi.org/10.1016/j.cardiores.2003.11.039 PubMedCrossRef

150.

Garcia-Dorado D, Ruiz-Meana M, Inserte J, Rodriguez-Sinovas A, Piper HM (2012) Calcium-mediated cell death during myocardial reperfusion. Cardiovasc Res 94:168–180. https://doi.org/10.1093/cvr/cvs116 PubMedCrossRef

151.

Garcia-Dorado D, Théroux P, Duran JM, Solares J, Alonso J, Sanz E, Munoz R, Elizaga J, Botas J, Fernandez-Avilés F, Soriano J, Esteban E (1992) Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 85:1160–1174. https://doi.org/10.1161/01.CIR.85.3.1160 PubMedCrossRef

152.

Garcia-Ruiz JM, Fernandez-Jimenez R, Garcia-Alvarez A, Pizarro G, Galan-Arriola C, Fernandez-Friera L, Mateos A, Nuno-Ayala M, Aguero J, Sanchez-Gonzalez J, Garcia-Prieto J, Lopez-Melgar B, Martinez-Tenorio P, Lopez-Martin GJ, Macias A, Perez-Asenjo B, Cabrera JA, Fernandez-Ortiz A, Fuster V, Ibanez B (2016) Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function. J Am Coll Cardiol 67:2093–2104. https://doi.org/10.1016/j.jacc.2016.02.050 PubMedCrossRef

153.

Garcia-Ruiz JM, Galan-Arriola C, Fernandez-Jimenez R, Aguero J, Sanchez-Gonzalez J, Garcia-Alvarez A, Nuno-Ayala M, Dube GP, Zafirelis Z, Lopez-Martin GJ, Bernal JA, Lara-Pezzi E, Fuster V, Ibanez B (2017) Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery. Basic Res Cardiol 112:17. https://doi.org/10.1007/s00395-017-0605-6 PubMedCrossRef

154.

Gargiulo S, Greco A, Gramanzini M, Esposito S, Affuso A, Brunetti A, Vesce G (2012) Mice anesthesia, analgesia, and care, part I: anesthetic considerations in preclinical research. ILAR J 53:E55–E69. https://doi.org/10.1093/ilar.53.1.55 PubMedCrossRef

155.

Gaspar A, Lourenco AP, Pereira MA, Azevedo P, Roncon-Albuquerque R Jr, Marques J, Leite-Moreira AF (2018) Randomized controlled trial of remote ischaemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI). Basic Res Cardiol 113:14. https://doi.org/10.1007/s00395-018-0672-3 PubMedCrossRef

156.

Gedik N, Maciel L, Schulte C, Skyschally A, Heusch G, Kleinbongard P (2017) Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning. Arch Med Sci 13:448–458. https://doi.org/10.5114/aoms.2016.61789 PubMedCrossRef

157.

Gelpi RJ, Morales C, Cohen MV, Downey JM (2002) Xanthine oxidase contributes to preconditioning’s preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol 97:40–46. https://doi.org/10.1007/s395-002-8386-0 PubMedCrossRef

158.

Gent S, Skyschally A, Kleinbongard P, Heusch G (2017) Ischemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3. Am J Physiol Heart Circ Physiol 312:H478–H484. https://doi.org/10.1152/ajpheart.00749.2016 PubMedCrossRef

159.

Gevi F, Campolo F, Naro F, Zolla L (2017) The cardioprotective effect of sildenafil is mediated by the activation of malate dehydrogenase and an increase in the malate-aspartate shuttle in cardiomyocytes. Biochem Pharmacol 127:60–70. https://doi.org/10.1016/j.bcp.2016.12.017 PubMedCrossRef

160.

Gidlöf O, Johnstone AL, Bader K, Khomtchouk BB, O’Reilly JJ, Celik S, Van Booven DJ, Wahlestedt C, Metzler B, Erlinge D (2016) Ischemic preconditioning confers epigenetic repression of mtor and induction of autophagy through G9a-dependent H3K9 dimethylation. J Am Heart Assoc 5:e004076. https://doi.org/10.1161/JAHA.116.004076 PubMedPubMedCentralCrossRef

161.

Giricz Z, Varga ZV, Baranyai T, Sipos P, Paloczi K, Kittel A, Buzas EI, Ferdinandy P (2014) Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol 68:75–78. https://doi.org/10.1016/j.yjmcc.2014.01.004 PubMedCrossRef

162.

Görbe A, Eder A, Varga ZV, Paloczi J, Hansen A, Ferdinandy P, Eschenhagen T (2015) Protection by the NO-Donor SNAP and BNP against hypoxia/reoxygenation in rat engineered heart tissue. PLoS One 10:e0132186. https://doi.org/10.1371/journal.pone.0132186 PubMedPubMedCentralCrossRef

163.

Görbe A, Varga ZV, Paloczi J, Rungarunlert S, Klincumhom N, Pirity MK, Madonna R, Eschenhagen T, Dinnyes A, Csont T, Ferdinandy P (2014) Cytoprotection by the NO-donor SNAP against ischemia/reoxygenation injury in mouse embryonic stem cell-derived cardiomyocytes. Mol Biotechnol 56:258–264. https://doi.org/10.1007/s12033-013-9704-2 PubMedCrossRef

164.

Gorog DA, Tanno M, Kabir AMN, Kanaganayagam GS, Bassi R, Fisher SG, Marber MS (2003) Varying susceptibility to myocardial infarction among C57BL/6 mice of different genetic background. J Mol Cell Cardiol 35:705–708. https://doi.org/10.1016/S0022-2828(03)00082-8 PubMedCrossRef

165.

Gregorich ZR, Chang YH, Ge Y (2014) Proteomics in heart failure: top-down or bottom-up? Pflugers Arch 466:1199–1209. https://doi.org/10.1007/s00424-014-1471-9 PubMedPubMedCentralCrossRef

166.

Grieve SM, Mazhar J, Callaghan F, Kok CY, Tandy S, Bhindi R, Figtree GA (2014) Automated quantification of myocardial salvage in a rat model of ischemia-reperfusion injury using 3D high-resolution magnetic resonance imaging (MRI). J Am Heart Assoc 3:e000956. https://doi.org/10.1161/JAHA.114.000956 PubMedPubMedCentralCrossRef

167.

Griffiths EJ, Halestrap AP (1995) Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307(Pt 1):93–98PubMedPubMedCentralCrossRef

168.

Group IEW (1999) ICH harmonised tripartite guideline. Statistical principles for clinical trials. Stat Med 18:1905–1942

169.

Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G (1993) Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol 265:H1401–H1410. https://doi.org/10.1152/ajpheart.1993.265.4.H1401 PubMedCrossRef

170.

Guo J, Zhu J, Ma L, Shi H, Hu J, Zhang S, Hou L, Xu F, An Y, Yu H, Ge J (2017) Chronic kidney disease exacerbates myocardial ischemia reperfusion injury: role of endoplasmic reticulum stress-mediated apoptosis. Shock. https://doi.org/10.1097/SHK.0000000000000970 PubMedCentralCrossRefPubMed

171.

Guo Y, Flaherty MP, Wu WJ, Tan W, Zhu X, Li Q, Bolli R (2012) Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of infarct size in 1074 mice. Basic Res Cardiol 107:288. https://doi.org/10.1007/s00395-012-0288-y PubMedPubMedCentralCrossRef

172.

Hale SL, Kloner RA (1997) Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia. Am J Physiol 273:H220–H227. https://doi.org/10.1152/ajpheart.1997.273.1.H220 PubMedCrossRef

173.

Hale SL, Mehra A, Leeka J, Kloner RA (2008) Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol 294:H421–H425PubMedCrossRef

174.

Halestrap AP, Clarke SJ, Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion—a target for cardioprotection. Cardiovasc Res 61:372–385. https://doi.org/10.1016/S0008-6363(03)00533-9 PubMedCrossRef

175.

Han JH, Lim SY, Lee MS, Lee WW (2015) Sodium [(1)(8)F]fluoride PET/CT in myocardial infarction. Mol Imaging Biol 17:214–221. https://doi.org/10.1007/s11307-014-0796-2 PubMedCrossRef

176.

Han S, Olonisakin TF, Pribis JP, Zupetic J, Yoon JH, Holleran KM, Jeong K, Shaikh N, Rubio DM, Lee JS (2017) A checklist is associated with increased quality of reporting preclinical biomedical research: a systematic review. PLoS One 12:e0183591. https://doi.org/10.1371/journal.pone.0183591 PubMedPubMedCentralCrossRef

177.

Handley MG, Medina RA, Nagel E, Blower PJ, Southworth R (2011) PET imaging of cardiac hypoxia: opportunities and challenges. J Mol Cell Cardiol 51:640–650. https://doi.org/10.1016/j.yjmcc.2011.07.005 PubMedPubMedCentralCrossRef

178.

Hartley CJ, Latson LA, Michael LH, Seidel CL, Lewis RM, Entman ML (1983) Doppler measurement of myocardial thickening with a single epicardial transducer. Am J Physiol 245:H1066–H1072PubMed

179.

Hausenloy D, Wynne A, Duchen M, Yellon D (2004) Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 109:1714–1717. https://doi.org/10.1161/01.CIR.0000126294.81407.7D PubMedCrossRef

180.

Hausenloy DJ, Barrabes JA, Bøtker HE, Davidson SM, Di Lisa F, Downey J, Engstrom T, Ferdinandy P, Carbrera-Fuentes HA, Heusch G, Ibanez B, Iliodromitis EK, Inserte J, Jennings R, Kalia N, Kharbanda R, Lecour S, Marber M, Miura T, Ovize M, Perez-Pinzon MA, Piper HM, Przyklenk K, Schmidt MR, Redington A, Ruiz-Meana M, Vilahur G, Vinten-Johansen J, Yellon DM, Garcia-Dorado D (2016) Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol 111:70. https://doi.org/10.1007/s00395-016-0588-8 PubMedPubMedCentralCrossRef

181.

Hausenloy DJ, Botker HE, Engstrom T, Erlinge D, Heusch G, Ibanez B, Kloner RA, Ovize M, Yellon DM, Garcia-Dorado D (2017) Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J 38:935–941. https://doi.org/10.1093/eurheartj/ehw145 PubMedCrossRef

182.

Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM, Investigators ET (2015) Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 373:1408–1417. https://doi.org/10.1056/NEJMoa1413534 PubMedCrossRef

183.

Hausenloy DJ, Duchen MR, Yellon DM (2003) Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 60:617–625. https://doi.org/10.1016/j.cardiores.2003.09.025 PubMedCrossRef

184.

Hausenloy DJ, Garcia-Dorado D, Erik Botker H, Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J, Madonna R, Ovize M, Perrino C, Prunier F, Schulz R, Sluijter JP, Van Laake LW, Vinten-Johansen J, Yellon DM, Ytrehus K, Heusch G, Ferdinandy P (2017) Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology working group on cellular biology of the heart. Cardiovasc Res 113:564–585. https://doi.org/10.1093/cvr/cvx049 PubMedCrossRef

185.

Hausenloy DJ, Kharbanda R, Rahbek Schmidt M, Moller UK, Ravkilde J, Okkels Jensen L, Engstrom T, Garcia Ruiz JM, Radovanovic N, Christensen EF, Sorensen HT, Ramlall M, Bulluck H, Evans R, Nicholas J, Knight R, Clayton T, Yellon DM, Botker HE (2015) Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J 36:1846–1848. https://doi.org/10.1093/eurheartj/ehv249 PubMedCrossRef

186.

Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM (2007) Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial. Lancet 370:575–579. https://doi.org/10.1016/S0140-6736(07)61296-3 PubMedCrossRef

187.

Headrick JP, Peart J, Hack B, Flood A, Matherne GP (2001) Functional properties and responses to ischaemia-reperfusion in Langendorff perfused mouse heart. Exp Physiol 86:703–716. https://doi.org/10.1111/j.1469-445X.2001.tb00035.x PubMedCrossRef

188.

Hegstad AC, Ytrehus K, Lindal S, Jorgensen L (1999) Ultrastructural alterations during the critical phase of reperfusion: a stereological study in buffer-perfused isolated rat hearts. Cardiovasc Pathol 8:279–289PubMedCrossRef

189.

Heimburger RF (1946) Injection into pericardial sac and ligation of coronary artery of the rat. Arch Surg 52:677–689CrossRef

190.

Heinzel FR, Luo Y, Dodoni G, Boengler K, Petrat F, Di Lisa F, de Groot H, Schulz R, Heusch G (2006) Formation of reactive oyxgen species at increased contraction frequency in rat cardiomyocytes. Cardiovasc Res 71:374–382. https://doi.org/10.1016/j.cardiores.2006.05.014 PubMedCrossRef

191.

Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, García-Dorado D, Di Lisa F, Schulz R, Heusch G (2005) Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 97:583–586. https://doi.org/10.1161/01.RES.0000181171.65293.65 PubMedCrossRef

192.

Helm M, Motorin Y (2017) Detecting RNA modifications in the epitranscriptome: predict and validate. Nat Rev Genet 18:275–291. https://doi.org/10.1038/nrg.2016.169 PubMedCrossRef

193.

Herrmann J, Lennon RJ, Jaffe AS, Holmes DR Jr, Rihal CS, Prasad A (2014) Defining the optimal cardiac troponin T threshold for predicting death caused by periprocedural myocardial infarction after percutaneous coronary intervention. Circ Cardiovasc Interv 7:533–542. https://doi.org/10.1161/CIRCINTERVENTIONS.113.000544 PubMedCrossRef

194.

Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G (1991) Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 69:1476–1486. https://doi.org/10.1161/01.RES.69.6.1476 PubMedCrossRef

195.

Heusch G (2018) Cardioprotection research must leave its comfort zone. Eur Heart J. https://doi.org/10.1093/eurheartj/ehy253 PubMedCrossRef

196.

Heusch G (2017) Critical issues for the translation of cardioprotection. Circ Res 120:1477–1486. https://doi.org/10.1161/CIRCRESAHA.117.310820 PubMedCrossRef

197.

Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381:166–175. https://doi.org/10.1016/S0140-6736(12)60916-7 PubMedCrossRef

198.

Heusch G (2016) The coronary circulation as a target of cardioprotection. Circ Res 118:1643–1658. https://doi.org/10.1161/CIRCRESAHA.116.308640 PubMedCrossRef

199.

Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116:674–699. https://doi.org/10.1161/CIRCRESAHA.116.305348 PubMedCrossRef

200.

Heusch G (2018) 25 years of remote ischemic conditioning: from laboratory curiosity to clinical outcome. Basic Res Cardiol 113:15. https://doi.org/10.1007/s00395-018-0673-2 PubMedCrossRef

201.

Heusch G (2015) Treatment of myocardial ischemia/reperfusion injury by ischemic and pharmacological postconditioning. Compr Physiol 5:1123–1145. https://doi.org/10.1002/cphy.c140075 PubMedCrossRef

202.

Heusch G, Bøtker HE, Przyklenk K, Redington A, Yellon D (2015) Remote ischemic conditioning. J Am Coll Cardiol 65:177–195. https://doi.org/10.1016/j.jacc.2014.10.031 PubMedPubMedCentralCrossRef

203.

Heusch G, Gersh BJ (2017) The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 38:774–784. https://doi.org/10.1093/eurheartj/ehw224 PubMedCrossRef

204.

Heusch G, Gersh BJ (2015) ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not! Eur Heart J 37:200–201. https://doi.org/10.1093/eurheartj/ehv606 PubMedCrossRef

205.

Heusch G, Musiolik J, Gedik N, Skyschally A (2011) Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 109:1302–1308. https://doi.org/10.1161/CIRCRESAHA.111.255604 PubMedCrossRef

206.

Heusch G, Rassaf T (2016) Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning. Circ Res 119:676–695. https://doi.org/10.1161/CIRCRESAHA.116.308736 PubMedCrossRef

207.

Heusch G, Schulz R (2011) Preservation of peripheral vasodilation as a surrogate of cardioprotection? The mechanistic role of ATP-dependent potassium channels and the mitochondrial permeability transition pore. Eur Heart J 32:1184–1186PubMedCrossRef

208.

Heusch G, Skyschally A, Kleinbongard P (2018) Coronary microembolization and microvascular dysfunction. Int J Cardiol 258:17–23. https://doi.org/10.1016/j.ijcard.2018.02.010 PubMedCrossRef

209.

Heusch G, Skyschally A, Schulz R (2011) The in situ pig heart with regional ischemia/reperfusion—ready for translation. J Mol Cell Cardiol 50:951–963. https://doi.org/10.1016/j.yjmcc.2011.02.016 PubMedCrossRef

210.

Heusch P, Nensa F, Heusch G (2015) Is MRI really the gold standard for the quantification of salvage from myocardial infarction? Circ Res 117:222–224. https://doi.org/10.1161/CIRCRESAHA.117.306929 PubMedCrossRef

211.

Hildebrandt HA, Kreienkamp V, Gent S, Kahlert P, Heusch G, Kleinbongard P (2016) Kinetics and signal activation properties of circulating factor(s) from healthy volunteers undergoing remote ischemic pre-conditioning. JACC Basic Transl Sci 1:3–13. https://doi.org/10.1016/j.jacbts.2016.01.007 PubMedPubMedCentralCrossRef

212.

Hooijmans CR, de Vries R, Leenaars M, Curfs J, Ritskes-Hoitinga M (2011) Improving planning, design, reporting and scientific quality of animal experiments by using the gold standard publication checklist, in addition to the ARRIVE guidelines. Br J Pharmacol 162:1259–1260. https://doi.org/10.1111/j.1476-5381.2010.01128.x PubMedPubMedCentralCrossRef

213.

Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O’Sullivan M, Dutka DP (2009) Cardiac remote ischemic preconditioning in coronary stenting (CRISP Stent) study: a prospective, randomized control trial. Circulation 119:820–827. https://doi.org/10.1161/CIRCULATIONAHA.108.809723 PubMedCrossRef

214.

Hou Y, Huang C, Cai X, Zhao J, Guo W (2011) Improvements in the establishment of a rat myocardial infarction model. J Int Med Res 39:1284–1292. https://doi.org/10.1177/147323001103900416 PubMedCrossRef

215.

Hsieh CW, Chu CH, Lee HM, Yuan Yang W (2015) Triggering mitophagy with far-red fluorescent photosensitizers. Sci Rep 5:10376. https://doi.org/10.1038/srep10376 PubMedPubMedCentralCrossRef

216.

Huang WQ, Wen JL, Lin RQ, Wei P, Huang F (2017) Effects of mTOR/NF-kappaB signaling pathway and high thoracic epidural anesthesia on myocardial ischemia-reperfusion injury via autophagy in rats. J Cell Physiol. https://doi.org/10.1002/jcp.26320 PubMedCentralCrossRefPubMed

217.

Ibanez B, Prat-Gonzalez S, Speidl WS, Vilahur G, Pinero A, Cimmino G, Garcia MJ, Fuster V, Sanz J, Badimon JJ (2007) Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 115:2909–2916. https://doi.org/10.1161/CIRCULATIONAHA.106.679639 PubMedCrossRef

218.

Iliodromitis EK, Andreadou I, Prokovas E, Zoga A, Farmakis D, Fotopoulou T, Ioannidis K, Paraskevaidis IA, Kremastinos DT (2010) Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation. Basic Res Cardiol 105:193–203. https://doi.org/10.1007/s00395-009-0078-3 PubMedCrossRef

219.

Iliodromitis EK, Kremastinos DT, Katritsis DG, Papadopoulos CC, Hearse DJ (1997) Multiple cycles of preconditioning cause loss of protection in open-chest rabbits. J Mol Cell Cardiol 29:915–920. https://doi.org/10.1006/jmcc.1996.0328 PubMedCrossRef

220.

Iliodromitis EK, Zoga A, Vrettou A, Andreadou I, Paraskevaidis IA, Kaklamanis L, Kremastinos DT (2006) The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 188:356–362. https://doi.org/10.1016/j.atherosclerosis.2005.11.023 PubMedCrossRef

221.

Ingram DL, Legge KF (1970) Variations in deep body temperature in the young unrestrained pig over the 24 hour period. J Physiol 210:989–998PubMedPubMedCentralCrossRef

222.

Inserte J, Cardona M, Poncelas-Nozal M, Hernando V, Vilardosa U, Aluja D, Parra VM, Sanchis D, Garcia-Dorado D (2016) Studies on the role of apoptosis after transient myocardial ischemia: genetic deletion of the executioner caspases-3 and -7 does not limit infarct size and ventricular remodeling. Basic Res Cardiol 111:18. https://doi.org/10.1007/s00395-016-0537-6 PubMedCrossRef

223.

Isorni MA, Casanova A, Piquet J, Bellamy V, Pignon C, Puymirat E, Menasche P (2015) Comparative analysis of methods to induce myocardial infarction in a closed-chest rabbit model. Biomed Res Int 2015:893051. https://doi.org/10.1155/2015/893051 PubMedPubMedCentralCrossRef

224.

Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP (2003) Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 549:513–524. https://doi.org/10.1113/jphysiol.2003.034231 PubMedPubMedCentralCrossRef

225.

Jensen RV, Stottrup NB, Kristiansen SB, Bøtker HE (2012) Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients. Basic Res Cardiol 107:285. https://doi.org/10.1007/s00395-012-0285-1 PubMedCrossRef

226.

Jespersen NR, Yokota T, Stottrup NB, Bergdahl A, Paelestik KB, Povlsen JA, Dela F, Botker HE (2017) Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion. J Physiol 595:3765–3780. https://doi.org/10.1113/JP273408 PubMedPubMedCentralCrossRef

227.

Johns TN, Olson BJ (1954) Experimental myocardial infarction. I. A method of coronary occlusion in small animals. Ann Surg 140:675–682PubMedPubMedCentralCrossRef

228.

Johnsen J, Pryds K, Salman R, Lofgren B, Kristiansen SB, Botker HE (2016) The remote ischemic preconditioning algorithm: effect of number of cycles, cycle duration and effector organ mass on efficacy of protection. Basic Res Cardiol 111:10. https://doi.org/10.1007/s00395-016-0529-6 PubMedCrossRef

229.

Jonassen AK, Sack MN, Mjos OD, Yellon DM (2001) Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89:1191–1198. https://doi.org/10.1161/hh2401.101385 PubMedCrossRef

230.

Jones SP, Tang XL, Guo Y, Steenbergen C, Lefer DJ, Kukreja RC, Kong M, Li Q, Bhushan S, Zhu X, Du J, Nong Y, Stowers HL, Kondo K, Hunt GN, Goodchild TT, Orr A, Chang CC, Ockaili R, Salloum FN, Bolli R (2015) The NHLBI-sponsored consortium for preclinicAL assESsment of cARdioprotective therapies (CAESAR): a new paradgm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. Circ Res 116:572–586. https://doi.org/10.1161/CIRCRESAHA.116.305462 PubMedCrossRef

231.

Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C (2005) Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. Faseb J 19:419–421. https://doi.org/10.1096/fj.04-2622fje PubMedCrossRef

232.

Juhaszova M, Zorov DB, Kim S-H, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ (2004) Glycogen synthase kinase-3ß mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113:1535–1549. https://doi.org/10.1172/JCI200419906 PubMedPubMedCentralCrossRef

233.

Kadipasaoglu KA, Bennink GW, Conger JL, Birovljev S, Sartori M, Clubb FJ Jr, Noda H, Ferguson JJ, Frazier OH (1993) An ex vivo model for the reperfusion of explanted human hearts. Tex Heart Inst J 20:33–39PubMedPubMedCentral

234.

Kahlert P, Hildebrandt HA, Patsalis PC, Al-Rashid F, Jánosi RA, Nensa F, Schlosser TW, Schlamann M, Wendt D, Thielmann M, Kottenberg E, Frey U, Neuhäuser M, Forsting M, Jakob HG, Rassaf T, Peters J, Heusch G, Kleinbongard P (2017) No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: interim-analysis of a randomized single-blinded, placebo-controlled, single-center trial. Int J Cardiol 231:248–254. https://doi.org/10.1016/j.ijcard.2016.12.005 PubMedCrossRef

235.

Kalogeris T, Baines CP, Krenz M, Korthuis RJ (2012) Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 298:229–317. https://doi.org/10.1016/B978-0-12-394309-5.00006-7 PubMedPubMedCentralCrossRef

236.

Kaludercic N, Carpi A, Nagayama T, Sivakumaran V, Zhu G, Lai EW, Bedja D, De Mario A, Chen K, Gabrielson KL, Lindsey ML, Pacak K, Takimoto E, Shih JC, Kass DA, Di Lisa F, Paolocci N (2014) Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. Antioxid Redox Signal 20:267–280. https://doi.org/10.1089/ars.2012.4616 PubMedPubMedCentralCrossRef

237.

Kaludercic N, Deshwal S, Di LF (2014) Reactive oxygen species and redox compartmentalization. Front Physiol 5:285. https://doi.org/10.3389/fphys.2014.00285 PubMedPubMedCentralCrossRef

238.

Kalyanaraman B, Darley-Usmar V, Davies KJ, Dennery PA, Forman HJ, Grisham MB, Mann GE, Moore K, Roberts LJ, Ischiropoulos H (2012) Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med 52:1–6. https://doi.org/10.1016/j.freeradbiomed.2011.09.030 PubMedCrossRef

239.

Kanno S, Lerner DL, Schuessler RB, Betsuyaku T, Yamada KA, Saffitz JE, Kovacs A (2002) Echocardiographic evaluation of ventricular remodeling in a mouse model of myocardial infarction. J Am Soc Echocardiogr 15:601–609. https://doi.org/10.1067/mje.2002.117560 PubMedCrossRef

240.

Karmazyn M, Neely JR (1989) Inhibition of post-ischemic ventricular recovery by low concentrations of prostacyclin in isolated working rat hearts: dependency on concentration, ischemia duration, calcium and relationship to myocardial energy metabolism. J Mol Cell Cardiol 21:335–346PubMedCrossRef

241.

Kass DA, Beyar R, Lankford E, Heard M, Maughan WL, Sagawa K (1989) Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations. Circulation 79:167–178PubMedCrossRef

242.

Kass DA, Hare JM, Georgakopoulos D (1998) Murine cardiac function: a cautionary tail. Circ Res 82:519–522. https://doi.org/10.1161/01.RES.82.4.519 PubMedCrossRef

243.

Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, Martinoff S, Neumann FJ, Nekolla S, Blasini R, Seyfarth M, Schwaiger M, Schomig A (2002) Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet 359:920–925. https://doi.org/10.1016/S0140-6736(02)08022-4 PubMedCrossRef

244.

Katsanos K, Mitsos S, Koletsis E, Bravou V, Karnabatidis D, Kolonitsiou F, Diamantopoulos A, Dougenis D, Siablis D (2012) Transauricular embolization of the rabbit coronary artery for experimental myocardial infarction: comparison of a minimally invasive closed-chest model with open-chest surgery. J Cardiothorac Surg 7:16. https://doi.org/10.1186/1749-8090-7-16 PubMedPubMedCentralCrossRef

245.

Katz EB, Steinhelper ME, Delcarpio JB, Daud AI, Claycomb WC, Field LJ (1992) Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am J Physiol 262:H1867–H1876. https://doi.org/10.1152/ajpheart.1992.262.6.H1867 PubMedCrossRef

246.

Kaufman N, Gavan TL, Hill RW (1959) Experimental myocardial infarction in the rat. AMA Arch Pathol 67:482–488PubMed

247.

Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR (2002) Is isoflurane-induced preconditioning dose related? Anesthesiology 96:675–680PubMedCrossRef

248.

Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister AF (2002) Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106:2881–2883. https://doi.org/10.1161/01.CIR.0000043806.51912.9B PubMedCrossRef

249.

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412. https://doi.org/10.1371/journal.pbio.1000412 PubMedPubMedCentralCrossRef

250.

Kim RJ, Fieno DS, Parrish TB, Harris K, Chen E-L, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MIRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992–2002PubMedCrossRef

251.

Kimes BW, Brandt BL (1976) Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98:367–381PubMedCrossRef

252.

Kleinbongard P, Amanakis G, Skyschally A, Heusch G (2018) Reflection of cardioprotection by remote ischemic perconditioning in attenuated ST-segment elevation during ongoing coronary occlusion in pigs: evidence for cardioprotection from ischemic injury. Circ Res 122:1102–1108. https://doi.org/10.1161/CIRCRESAHA.118.312784 PubMedCrossRef

253.

Kleinbongard P, Gedik N, Kirca M, Stoian L, Frey U, Zandi A, Thielmann M, Jakob H, Peters J, Kamler M, Heusch G (2018) Mitochondrial and contractile function of human right atrial tissue in response to remote ischemic conditioning. J Am Heart Assoc. https://doi.org/10.1161/JAHA.118.009540 CrossRefPubMedPubMedCentral

254.

Kleinbongard P, Heusch G (2015) Extracellular signalling molecules in the ischaemic/reperfused heart—druggable and translatable for cardioprotection? Br J Pharmacol 172:2010–2025. https://doi.org/10.1111/bph.12902 PubMedCrossRef

255.

Kleinbongard P, Skyschally A, Gent S, Pesch M, Heusch G (2018) STAT3 as a common signal of ischemic conditioning: a lesson on “rigor and reproducibility” in preclinical studies on cardioprotection. Basic Res Cardiol 113:3. https://doi.org/10.1007/s00395-017-0660-z CrossRefPubMed

256.

Kloner RA, Jennings RB (2001) Consequences of brief ischemia: stunning, preconditioning, and their clinical implications. Part 2. Circulation 104:3158–3167. https://doi.org/10.1161/hc5001.100039 PubMedCrossRef

257.

Kohlhaas M, Liu T, Knopp A, Zeller T, Ong MF, Bohm M, O’Rourke B, Maack C (2010) Elevated cytosolic Na⁺ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation 121:1606–1613. https://doi.org/10.1161/CIRCULATIONAHA PubMedPubMedCentralCrossRef

258.

Kohn DF, Martin TE, Foley PL, Morris TH, Swindle MM, Vogler GA, Wixson SK, Members ATF (2007) Public statement: guidelines for the assessment and management of pain in rodents and rabbits. J Am Assoc Lab Anim Sci 46:97–108PubMed

259.

Koncsos G, Varga ZV, Baranyai T, Ferdinandy P, Schulz R, Giricz Z, Boengler K (2018) Nagarse treatment of cardiac subsarcolemmal and interfibrillar mitochondria leads to artefacts in mitochondrial protein quantification. J Pharmacol Toxicol Methods 91:50–58. https://doi.org/10.1016/j.vascn.2018.01.004 PubMedCrossRef

260.

Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G (2014) Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg 147:376–382. https://doi.org/10.1016/j.jtcvs.2013.01.005 PubMedCrossRef

261.

Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J (2012) Protection by remote ischaemic preconditioning during coronary artery bypass grafting with isoflurane but not with propofol anesthesia—a clinical trial. Acta Anaesthesiol Scand 56:30–38. https://doi.org/10.1111/j.1399-6576.2011.02585.x PubMedCrossRef

262.

Kowallik P, Schulz R, Guth BD, Schade A, Paffhausen W, Gross R, Heusch G (1991) Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 83:974–982. https://doi.org/10.1161/01.CIR.83.3.974 PubMedCrossRef

263.

Kumar D, Hacker TA, Buck J, Whitesell LF, Kaji EH, Douglas PS, Kamp TJ (2005) Distinct mouse coronary anatomy and myocardial infarction consequent to ligation. Coron Artery Dis 16:41–44PubMedCrossRef

264.

Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, Karas RH, Udelson JE (2003) Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 146:168–174. https://doi.org/10.1016/S0002-8703(03)00094-2 PubMedCrossRef

265.

Kuznetsov AV, Javadov S, Sickinger S, Frotschnig S, Grimm M (2015) H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation. Biochim Biophys Acta 1853:276–284. https://doi.org/10.1016/j.bbamcr.2014.11.015 PubMedCrossRef

266.

Lambert EA, Thomas CJ, Hemmes R, Eikelis N, Pathak A, Schlaich MP, Lambert GW (2016) Sympathetic nervous response to ischemia-reperfusion injury in humans is altered with remote ischemic preconditioning. Am J Physiol Heart Circ Physiol 311:H364–H370. https://doi.org/10.1152/ajpheart.00369.2016 PubMedCrossRef

267.

Lampert FM, Matt P, Grapow M, Lefkovits I, Zerkowski HR, Grussenmeyer T (2007) “Turnover proteome” of human atrial trabeculae. J Proteome Res 6:4458–4468. https://doi.org/10.1021/pr0704229 PubMedCrossRef

268.

go back to reference Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann Y, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowki J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ, Szustakowki J, International Human Genome Sequencing C (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921. https://doi.org/10.1038/35057062 PubMedCrossRef Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann Y, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowki J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ, Szustakowki J, International Human Genome Sequencing C (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921. https://doi.org/10.1038/35057062 PubMedCrossRef

269.

Langendorff O (1895) Untersuchungen am überlebenden Säugetierherzen. Pflügers Arch 61:291–332CrossRef

270.

Larsen JR, Aagaard S, Lie RH, Sloth E, Hasenkam JM (2008) Sevoflurane improves myocardial ischaemic tolerance in a closed-chest porcine model. Acta Anaesthesiol Scand 52:1400–1410PubMedCrossRef

271.

Larsen TS, Belke DD, Sas R, Giles WR, Severson DL, Lopaschuk GD, Tyberg JV (1999) The isolated working mouse heart: methodological considerations. Pflugers Arch 437:979–985PubMedCrossRef

272.

Lau E, Cao Q, Lam MPY, Wang J, Ng DCM, Bleakley BJ, Lee JM, Liem DA, Wang D, Hermjakob H, Ping P (2018) Integrated omics dissection of proteome dynamics during cardiac remodeling. Nat Commun 9:120. https://doi.org/10.1038/s41467-017-02467-3 PubMedPubMedCentralCrossRef

273.

Lee BH, Kim WH, Choi MJ, Rho JR, Kim WG (2002) Chronic heart failure model in rabbits based on the concept of the bifurcation/trifurcation coronary artery branching pattern. Artif Organs 26:360–365. https://doi.org/10.1046/j.1525-1594.2002.06881 PubMedCrossRef

274.

Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, Kar S, Dohad S, Kass R, Eigler N, Trento A, Shah PK, Makkar RR (2006) Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 47:864–870. https://doi.org/10.1016/j.jacc.2005.09.072 PubMedCrossRef

275.

Lemoine S, Zhu L, Grard JL, Hanouz JL (2017) Sevoflurane induced cardioprotection in coronary artery bypass graft surgery: randomised trial with clinical and ex vivo endpoints. Anaesth Crit Care Pain Med. https://doi.org/10.1016/j.accpm.2017.05.009 PubMedCrossRef

276.

Liao SS, Ruan QY, Lin MY, Yan L (2012) Value of segmental myocardial strain by 2-dimensional strain echocardiography for assessment of scar area induced in a rat model of myocardial infarction. Cardiovasc Ultrasound 10:17. https://doi.org/10.1186/1476-7120-10-17 PubMedPubMedCentralCrossRef

277.

Liddy KA, White MY, Cordwell SJ (2013) Functional decorations: post-translational modifications and heart disease delineated by targeted proteomics. Genome Med 5:20. https://doi.org/10.1186/gm424 PubMedPubMedCentralCrossRef

278.

Lindenmayer GE, Sordahl LA, Schwartz A (1968) Reevaluation of oxidative phosphorylation in cardiac mitochondria from normal animals and animals in heart failure. Circ Res 23:439–450. https://doi.org/10.1161/01.RES.23.3.439 PubMedCrossRef

279.

Lindsey ML, Bolli R, Canty JM, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner R, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G (2018) Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol 314:H812–H838. https://doi.org/10.1152/ajpheart.00335.2017 PubMedPubMedCentralCrossRef

280.

Lindsey ML, Mayr M, Gomes AV, Delles C, Arrell DK, Murphy AM, Lange RA, Costello CE, Jin YF, Laskowitz DT, Sam F, Terzic A, Van Eyk J, Srinivas PR, American Heart Association Council on Functional G, Translational Biology CoCDitYCoCCCoC, Stroke Nursing CoH, Stroke C (2015) Transformative impact of proteomics on cardiovascular health and disease: a scientific statement from the american heart association. Circulation 132:852–872. https://doi.org/10.1161/cir.0000000000000226 PubMedCrossRef

281.

Liu GS, Thornton J, van Winkle DM, Stanley AWH, Olsson RA, Downey JM (1991) Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84:350–356PubMedCrossRef

282.

Liu YH, Yang XP, Nass O, Sabbah HN, Peterson E, Carretero OA (1997) Chronic heart failure induced by coronary artery ligation in Lewis inbred rats. Am J Physiol 272:H722–H727PubMedCrossRef

283.

Lochner A, Genade S, Moolman JA (2003) Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol 98:337–346. https://doi.org/10.1007/s00395-003-0427-6 PubMedCrossRef

284.

Lopez JE, Jaradeh K, Silva E, Aminololama-Shakeri S, Simpson PC (2017) A method to increase reproducibility in adult ventricular myocyte sizing and flow cytometry: avoiding cell size bias in single cell preparations. PLoS One 12:e0186792. https://doi.org/10.1371/journal.pone.0186792 PubMedPubMedCentralCrossRef

285.

Lougiakis N, Papapetropoulos A, Gikas E, Toumpas S, Efentakis P, Wedmann R, Zoga A, Zhou Z, Iliodromitis EK, Skaltsounis AL, Filipovic MR, Pouli N, Marakos P, Andreadou I (2016) Synthesis and pharmacological evaluation of novel adenine-hydrogen sulfide slow release hybrids designed as multitarget cardioprotective agents. J Med Chem 59:1776–1790. https://doi.org/10.1021/acs.jmedchem.5b01223 PubMedCrossRef

286.

Ludbrook J (1994) Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 28:303–311PubMedCrossRef

287.

Lukyanov KA, Belousov VV (2014) Genetically encoded fluorescent redox sensors. Biochim Biophys Acta 1840:745–756. https://doi.org/10.1016/j.bbagen.2013.05.030 PubMedCrossRef

288.

Luo D, Yao YY, Li YF, Sheng ZL, Tang Y, Fang F, Fang K, Ma GS, Teng GJ (2012) Myocardial infarction quantification with late gadolinium-enhanced magnetic resonance imaging in rats using a 7-T scanner. Cardiovasc Pathol 21:112–119. https://doi.org/10.1016/j.carpath.2011.03.005 PubMedCrossRef

289.

Maack C, O’Rourke B (2007) Excitation-contraction coupling and mitochondrial energetics. Basic Res Cardiol 102:369–392. https://doi.org/10.1007/s00395-007-0666-z PubMedPubMedCentralCrossRef

290.

Madonna R, Ferdinandy P, De CR, Willerson JT, Marian AJ (2014) Recent developments in cardiovascular stem cells. Circ Res 115:e71–e78. https://doi.org/10.1161/CIRCRESAHA.114.305567 PubMedCrossRef

291.

Madonna R, Van Laake LW, Davidson SM, Engel FB, Hausenloy DJ, Lecour S, Leor J, Perrino C, Schulz R, Ytrehus K, Landmesser U, Mummery CL, Janssens S, Willerson J, Eschenhagen T, Ferdinandy P, Sluijter JP (2016) Position paper of the European Society of Cardiology working group cellular biology of the heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Eur Heart J 37:1789–1798. https://doi.org/10.1093/eurheartj/ehw113 PubMedPubMedCentralCrossRef

292.

Magoon KE, Hsu WH, Hembrough FB (1988) The influence of atropine on the cardiopulmonary effects of a xylazine-ketamine combination in dogs. Arch Int Pharmacodyn Ther 293:143–153PubMed

293.

Malinouski M, Zhou Y, Belousov VV, Hatfield DL, Gladyshev VN (2011) Hydrogen peroxide probes directed to different cellular compartments. PLoS One 6:e14564. https://doi.org/10.1371/journal.pone.0014564 PubMedPubMedCentralCrossRef

294.

Manders WT, Vatner SF (1976) Effects of sodium pentobarbital anesthesia on left ventricular function and distribution of cardiac output in dogs, with particular reference to the mechanism for tachycardia. Circ Res 39:512–517PubMedCrossRef

295.

Manintveld OC, Te Lintel Hekkert M, van den Bos EJ, Suurenbroek GM, Dekkers DH, Verdouw PD, Lamers JM, Duncker DJ (2007) Cardiac effects of postconditioning depend critically on the duration of index ischemia. Am J Physiol Heart Circ Physiol 292:H1551–H1560. https://doi.org/10.1152/ajpheart.00151.2006 PubMedCrossRef

296.

Mapara M, Thomas BS, Bhat KM (2012) Rabbit as an animal model for experimental research. Dent Res J (Isfahan) 9:111–118. https://doi.org/10.4103/1735-3327.92960 CrossRef

297.

Martin C, Schulz R, Post H, Boengler K, Kelm M, Kleinbongard P, Gres P, Skyschally A, Konietzka I, Heusch G (2007) Microdialysis-based analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia. Cardiovasc Res 74:46–55. https://doi.org/10.1016/j.cardiores.2006.12.020 PubMedCrossRef

298.

Menard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P (1999) Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J Biol Chem 274:29063–29070PubMedCrossRef

299.

Mersmann J, Latsch K, Habeck K, Zacharowski K (2011) Measure for measure-determination of infarct size in murine models of myocardial ischemia and reperfusion: a systematic review. Shock 35:449–455. https://doi.org/10.1097/SHK.0b013e318208af64 PubMedCrossRef

300.

Mewton N, Croisille P, Gahide G, Rioufol G, Bonnefoy E, Sanchez I, Cung TT, Sportouch C, Angoulvant D, Finet G, ndre-Fouet X, Derumeaux G, Piot C, Vernhet H, Revel D, Ovize M (2010) Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol 55:1200–1205. https://doi.org/10.1016/j.jacc.2009.10.052 PubMedCrossRef

301.

Mewton N, Rapacchi S, Augeul L, Ferrera R, Loufouat J, Boussel L, Micolich A, Rioufol G, Revel D, Ovize M, Croisille P (2011) Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model. Basic Res Cardiol 106:1247–1257. https://doi.org/10.1007/s00395-011-0214-8 PubMedCrossRef

302.

Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, Boning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Schon J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K, Collaborators RIS (2015) A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 373:1397–1407. https://doi.org/10.1056/NEJMoa1413579 PubMedCrossRef

303.

Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM (1995) Myocardial ischemia and reperfusion: a murine model. Am J Physiol 269:H2147–H2154PubMed

304.

Michelsen MM, Stottrup NB, Schmidt MR, Lofgren B, Jensen RV, Tropak M, St-Michel EJ, Redington AN, Bøtker HE (2012) Exercise-induced cardioprotection is mediated by a bloodborne, transferable factor. Basic Res Cardiol 107:260–269. https://doi.org/10.1007/s00395-012-0260-x PubMedCrossRef

305.

Miki T, Liu GS, Cohen MV, Downey JM (1998) Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction? Basic Res Cardiol 93:372–383PubMedCrossRef

306.

Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ (1995) Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 92:334–341. https://doi.org/10.1161/01.CIR.92.3.334 PubMedCrossRef

307.

Mjos OD, Ichihara K, Fellenius E, Myrmel T, Neely JR (1991) Fatty acids suppress recovery of heart function after hypothermic perfusion. Ann Thorac Surg 52:965–970PubMedCrossRef

308.

Monge C, Beraud N, Tepp K, Pelloux S, Chahboun S, Kaambre T, Kadaja L, Roosimaa M, Piirsoo A, Tourneur Y, Kuznetsov AV, Saks V, Seppet E (2009) Comparative analysis of the bioenergetics of adult cardiomyocytes and nonbeating HL-1 cells: respiratory chain activities, glycolytic enzyme profiles, and metabolic fluxes. Can J Physiol Pharmacol 87:318–326. https://doi.org/10.1139/Y09-018 PubMedCrossRef

309.

Morris SD, Yellon DM (1997) Angiotensin-converting enzyme inhibitiors potentiate preconditioning trough bradykinin B2 receptor activation in human heart. J Am Coll Cardiol 29:1599–1606PubMedCrossRef

310.

Morrissey PJ, Murphy KR, Daley JM, Schofield L, Turan NN, Arunachalam K, Abbott JD, Koren G (2017) A novel method of standardized myocardial infarction in aged rabbits. Am J Physiol Heart Circ Physiol 312:H959–H967. https://doi.org/10.1152/ajpheart.00582.2016 PubMedPubMedCentralCrossRef

311.

Mruck S, Henneken H, Dragu A, Stuttgen B, Tenderich G, Korfer R, Holubarsch C, Kuwert T (2000) Force-generating preparation from human atria as a model for studying myocardial uptake of radiopharmaceuticals. J Nucl Med 41:1587–1593PubMed

312.

Murphy E, Steenbergen C (2007) Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res 75:478–486. https://doi.org/10.1016/j.cardiores.2007.03.025 PubMedCrossRef

313.

Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136. https://doi.org/10.1161/01.CIR.74.5.1124 PubMedCrossRef

314.

Muscari C, Gamberini C, Bonafe F, Giordano E, Bianchi C, Lenaz G, Caldarera CM (2004) Evaluation of cellular energetics by the pasteur effect in intact cardiomyoblasts and isolated perfused hearts. Mol Cell Biochem 258:91–97PubMedCrossRef

315.

Nassenstein K, Breuckmann F, Bucher C, Kaiser G, Konorza T, Schafer L, Konietzka I, de Greiff A, Heusch G, Erbel R, Barkhausen J (2008) How much myocardial damage is necessary to enable detection of focal late gadolinium enhancement at cardiac MR imaging? Radiology 249:829–835. https://doi.org/10.1148/radiol.2493080457 PubMedCrossRef

316.

Neely JR, Liebermeister H, Battersby EJ, Morgan HE (1967) Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol 212:804–814PubMed

317.

Nemoto EM, Frankel HM (1970) Cerebrovascular response during progressive hyperthermia in dogs. Am J Physiol 218:1060–1064. https://doi.org/10.1152/ajplegacy.1970.218.4.1060 PubMedCrossRef

318.

Nensa F, Poeppel T, Tezgah E, Heusch P, Nassenstein K, Mahabadi AA, Forsting M, Bockisch A, Erbel R, Heusch G, Schlosser T (2015) Integrated FDG PET/MR imaging for the assessment of myocardial salvage in reperfused acute myocardial infarction. Radiology 276:400–407. https://doi.org/10.1148/radiol.2015140564 PubMedCrossRef

319.

Neuhäuser M (2006) How to deal with multiple endpoints in clinical trials. Fundam Clin Pharmacol 20:515–523. https://doi.org/10.1111/j.1472-8206.2006.00437.x PubMedCrossRef

320.

Nickel AG, von Hardenberg A, Hohl M, Loffler JR, Kohlhaas M, Becker J, Reil JC, Kazakov A, Bonnekoh J, Stadelmaier M, Puhl SL, Wagner M, Bogeski I, Cortassa S, Kappl R, Pasieka B, Lafontaine M, Lancaster CR, Blacker TS, Hall AR, Duchen MR, Kastner L, Lipp P, Zeller T, Muller C, Knopp A, Laufs U, Bohm M, Hoth M, Maack C (2015) Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure. Cell Metab 22:472–484. https://doi.org/10.1016/j.cmet.2015.07.008 PubMedCrossRef

321.

Nippert F, Schreckenberg R, Schlüter KD (2017) Isolation and cultivation of adult rat cardiomyocytes. J Vis Exp 128:e56634. https://doi.org/10.3791/56634 CrossRef

322.

Opitz CF, Mitchell GF, Pfeffer MA, Pfeffer JM (1995) Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats. Circulation 92:253–261. https://doi.org/10.1161/01.CIR.92.2.253 PubMedCrossRef

323.

Ostadal B, Ostadal P (2014) Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications. Br J Pharmacol 171:541–554. https://doi.org/10.1111/bph.12270 PubMedPubMedCentralCrossRef

324.

Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R (2010) Postconditioning and protection from reperfusion injury: where do we stand? Cardiovasc Res 87:406–423. https://doi.org/10.1093/cvr/cvq129 PubMedCrossRef

325.

Pagliaro P, Mancardi D, Rastaldo R, Penna C, Gattullo D, Miranda KM, Feelisch M, Wink DA, Kass DA, Paolocci N (2003) Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med 34:33–43. https://doi.org/10.1016/S0891-5849(02)01179-6 PubMedCrossRef

326.

Paillard M, Tubbs E, Thiebaut PA, Gomez L, Fauconnier J, Da Silva CC, Teixeira G, Mewton N, Belaidi E, Durand A, Abrial M, Lacampagne A, Rieusset J, Ovize M (2013) Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury. Circulation 128:1555–1565. https://doi.org/10.1161/CIRCULATIONAHA.113.001225 PubMedCrossRef

327.

Palmer JW, Tandler B, Hoppel CL (1977) Biochemical properties of subsarcolemmal and inter-fibrillar mitochondria isolated from rat cardiac-muscle. J Biol Chem 252:8731–8739PubMed

328.

Paloczi J, Varga ZV, Apati A, Szebenyi K, Sarkadi B, Madonna R, De Caterina R, Csont T, Eschenhagen T, Ferdinandy P, Gorbe A (2016) Exogenous nitric oxide protects human embryonic stem cell-derived cardiomyocytes against ischemia/reperfusion injury. Oxid Med Cell Longev 2016:4298945. https://doi.org/10.1155/2016/4298945 PubMedPubMedCentralCrossRef

329.

Papastefanou A, Balafas E, Durasevic S, Kostomitsopoulos N (2014) A simple method of endotracheal intubation in mice. Arch Biol Sci 66:241–244. https://doi.org/10.2298/ABS1401241P CrossRef

330.

Paradis JM, Maniar HS, Lasala JM, Kodali S, Williams M, Lindman BR, Damiano RJ Jr, Moon MR, Makkar RR, Thourani VH, Babaliaros V, Xu K, Ayele GM, Svensson L, Leon MB, Zajarias A (2015) Clinical and functional outcomes associated with myocardial injury after transfemoral and transapical transcatheter aortic valve replacement: a subanalysis from the PARTNER Trial (Placement of Aortic Transcatheter Valves). JACC Cardiovasc Interv 8:1468–1479. https://doi.org/10.1016/j.jcin.2015.06.018 PubMedPubMedCentralCrossRef

331.

Park SW, Lee SY, Park SJ, Lee SC, Gwon HC, Kim DK (2004) Quantitative assessment of infarct size in vivo by myocardial contrast echocardiography in a murine acute myocardial infarction model. Int J Cardiol 97:393–398. https://doi.org/10.1016/j.ijcard.2003.10.034 PubMedCrossRef

332.

Patten RD, Aronovitz MJ, Deras-Mejia L, Pandian NG, Hanak GG, Smith JJ, Mendelsohn ME, Konstam MA (1998) Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol 274:H1812–H1820PubMed

333.

Pavo N, Lukovic D, Zlabinger K, Zimba A, Lorant D, Goliasch G, Winkler J, Pils D, Auer K, Jan Ankersmit H, Giricz Z, Baranyai T, Sarkozy M, Jakab A, Garamvolgyi R, Emmert MY, Hoerstrup SP, Hausenloy DJ, Ferdinandy P, Maurer G, Gyongyosi M (2017) Sequential activation of different pathway networks in ischemia-affected and non-affected myocardium, inducing intrinsic remote conditioning to prevent left ventricular remodeling. Sci Rep 7:43958. https://doi.org/10.1038/srep43958 PubMedPubMedCentralCrossRef

334.

Penna C, Rastaldo R, Mancardi D, Raimondo S, Cappello S, Gattullo D, Losano G, Pagliario P (2006) Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation. Basic Res Cardiol 101:180–189. https://doi.org/10.1007/s00395-006-0584-5 PubMedCrossRef

335.

Penna C, Tullio F, Merlino A, Moro F, Raimondo S, Rastaldo R, Perrelli MG, Mancardi D, Pagliaro P (2009) Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Res Cardiol 104:390–402. https://doi.org/10.1007/s00395-008-0762-8 PubMedCrossRef

336.

Pereira SL, Ramalho-Santos J, Branco AF, Sardao VA, Oliveira PJ, Carvalho RA (2011) Metabolic remodeling during H9c2 myoblast differentiation: relevance for in vitro toxicity studies. Cardiovasc Toxicol 11:180–190. https://doi.org/10.1007/s12012-011-9112-4 PubMedCrossRef

337.

Perrino C, Barabasi AL, Condorelli G, Davidson SM, De Windt L, Dimmeler S, Engel FB, Hausenloy DJ, Hill JA, Van Laake LW, Lecour S, Leor J, Madonna R, Mayr M, Prunier F, Sluijter JPG, Schulz R, Thum T, Ytrehus K, Ferdinandy P (2017) Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position paper of the European Society of Cardiology working group on cellular biology of the heart. Cardiovasc Res 113:725–736. https://doi.org/10.1093/cvr/cvx070 PubMedPubMedCentralCrossRef

338.

Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P, Di Lisa F (1999) Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 76:725–734PubMedPubMedCentralCrossRef

339.

Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E (1979) Myocardial infarct size and ventricular function in rats. Circ Res 44:503–512. https://doi.org/10.1161/01.RES.44.4.503 PubMedCrossRef

340.

Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, Andre-Fouet X, Revel D, Kirkorian G, Monassier J-P, Derumeaux G, Ovize M (2008) Effect of cyclosporine on reperfusion injury in acute myocardial infarction. New Engl J Med 359:473–481. https://doi.org/10.1056/NEJMoa071142 PubMedCrossRef

341.

Porzio S, Masseroli M, Messori A, Forloni G, Olivetti G, Jeremic G, Riva E, Luvara G, Latini R (1995) A simple, automatic method for morphometric analysis of the left ventricle in rats with myocardial infarction. J Pharmacol Toxicol Methods 33:221–229PubMedCrossRef

342.

Povlsen JA, Lofgren B, Dalgas C, Jespersen NR, Johnsen J, Bøtker HE (2014) Frequent biomarker analysis in the isolated perfused heart reveals two distinct phases of reperfusion injury. Int J Cardiol 171:9–14. https://doi.org/10.1016/j.ijcard.2013.11.035 PubMedCrossRef

343.

Pryds K, Nielsen RR, Hoff CM, Tolbod LP, Bouchelouche K, Li J, Schmidt MR, Redington AN, Frokiaer J, Botker HE (2016) Effect of remote ischemic conditioning on myocardial perfusion in patients with suspected ischemic coronary artery disease. J Nucl Cardiol 25:887–896. https://doi.org/10.1007/s12350-016-0709-7 PubMedCrossRef

344.

Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P (1993) Regional ischemic “preconditioning” protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87:893–899. https://doi.org/10.1161/01.CIR.87.3.893 PubMedCrossRef

345.

Ramirez FD, Motazedian P, Jung RG, Di Santo P, MacDonald ZD, Moreland R, Simard T, Clancy AA, Russo JJ, Welch VA, Wells GA, Hibbert B (2017) Methodological rigor in preclinical cardiovascular studies: targets to enhance reproducibility and promote research translation. Circ Res 120:1916–1926. https://doi.org/10.1161/CIRCRESAHA.117.310628 PubMedPubMedCentralCrossRef

346.

Raya TE, Gay RG, Lancaster L, Aguirre M, Moffett C, Goldman S (1988) Serial changes in left ventricular relaxation and chamber stiffness after large myocardial infarction in rats. Circulation 77:1424–1431. https://doi.org/10.1161/01.CIR.77.6.1424 PubMedCrossRef

347.

Redfors B, Shao Y, Omerovic E (2012) Myocardial infarct size and area at risk assessment in mice. Exp Clin Cardiol 17:268–272PubMedPubMedCentral

348.

Reimer KA, Lowe JE, Rasmussen MM, Jennings RB (1977) The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56:786–794PubMedCrossRef

349.

Riva A, Tandler B, Loffredo F, Vazquez E, Hoppel C (2005) Structural differences in two biochemically defined populations of cardiac mitochondria. Am J Physiol Heart Circ Physiol 289:H868–H872. https://doi.org/10.1152/ajpheart.00866.2004 PubMedCrossRef

350.

Rizzuto R, Pozzan T (2006) Microdomains of intracellular Ca²⁺: molecular determinants and functional consequences. Physiol Rev 86:369–408. https://doi.org/10.1152/physrev.00004.2005 PubMedCrossRef

351.

Robinson KM, Janes MS, Pehar M, Monette JS, Ross MF, Hagen TM, Murphy MP, Beckman JS (2006) Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc Natl Acad Sci USA 103:15038–15043. https://doi.org/10.1073/pnas.0601945103 PubMedCrossRefPubMedCentral

352.

Rosen P, Adrian M, Feuerstein J, Reinauer H (1984) Glycolysis and glucose oxidation in the rat heart under nonrecirculating perfusion conditions. Basic Res Cardiol 79:307–312PubMedCrossRef

353.

Rossello X, Hall AR, Bell RM, Yellon DM (2016) Characterization of the Langendorff perfused isolated mouse heart model of global ischemia-reperfusion injury: impact of ischemia and reperfusion length on infarct sze and LDH release. J Cardiovasc Pharmacol Ther 21:286–295. https://doi.org/10.1177/1074248415604462 PubMedCrossRef

354.

Rossello X, Ibanez B (2018) Infarct size reduction by targeting ischemic injury: back to square one. Circ Res 122:1041–1043. https://doi.org/10.1161/CIRCRESAHA.118.312939 PubMedCrossRef

355.

Ruiz-Meana M, Garcia-Dorado D, Gonzales MA, Barrabes JA, Soler-Soler J (1995) Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyoyctes following transient metabolic inhibition. Cardiovasc Res 30:64–69PubMedCrossRef

356.

Ruiz-Meana M, Garcia-Dorado D, Julia M, Inserte J, Siegmund B, Ladilov Y, Piper M, Tritto FP, Gonzalez MA, Soler-Soler J (2000) Protective effect of HOE642, a selective blocker of Na⁺− H⁺ exchange, against the development of rigor contracture in rat ventricular myocytes. Exp Physiol 85:17–25PubMed

357.

Ruiz-Meana M, Garcia-Dorado D, Miro-Casas E, Abellan A, Soler-Soler J (2006) Mitochondrial Ca²⁺ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion. Cardiovasc Res 71:715–724. https://doi.org/10.1016/j.cardiores.2006.06.019 PubMedCrossRef

358.

Ruiz-Meana M, Inserte J, Fernandez-Sanz C, Hernando V, Miro-Casas E, Barba I, Garcia-Dorado D (2011) The role of mitochondrial permeability transition in reperfusion-induced cardiomyocyte death depends on the duration of ischemia. Basic Res Cardiol 106:1259–1268PubMedCrossRef

359.

Ruiz-Meana M, Nunez E, Miro-Casas E, Martinez-Acedo P, Barba I, Rodriguez-Sinovas A, Inserte J, Fernandez-Sanz C, Hernando V, Vazquez J, Garcia-Dorado D (2014) Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol. J Mol Cell Cardiol 68C:79–88. https://doi.org/10.1016/j.yjmcc.2014.01.001 CrossRef

360.

Sack MN (2006) Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc Res 72:210–219. https://doi.org/10.1016/j.cardiores.2006.07.010 PubMedCrossRef

361.

Saghaei M (2004) Random allocation software for parallel group randomized trials. BMC Med Res Methodol 4:26. https://doi.org/10.1186/1471-2288-4-26 PubMedPubMedCentralCrossRef

362.

Salto-Tellez M, Lim SY, El Oakley MR, Tang TPL, Almsherqi ZAM, Lim S-K (2004) Myocardial infarction in the C57BL/6J mouse. A quantifiable and highly reproducible experimental model. Cardiovasc Pathol 13:91–97. https://doi.org/10.1016/S1054-8807(03)00129-7 PubMedCrossRef

363.

Sam F, Sawyer DB, Chang DL, Eberli FR, Ngoy S, Jain M, Amin J, Apstein CS, Colucci WS (2000) Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 279:H422–H428. https://doi.org/10.1152/ajpheart.2000.279.1.H422 PubMedCrossRef

364.

Sanchis D, Mayorga M, Ballester M, Comella JX (2003) Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytes. Cell Death Differ 10:977–986. https://doi.org/10.1038/sj.cdd.4401267 PubMedCrossRef

365.

Sano Y, Ito S, Yoneda M, Nagasawa K, Matsuura N, Yamada Y, Uchinaka A, Bando YK, Murohara T, Nagata K (2016) Effects of various types of anesthesia on hemodynamics, cardiac function, and glucose and lipid metabolism in rats. Am J Physiol Heart Circ Physiol 311:H1360–H1366. https://doi.org/10.1152/ajpheart.00181.2016 PubMedCrossRef

366.

Sargent CA, Dzwonczyk S, Sleph P, Wilde M, Grover GJ (1994) Pyruvate increases threshold for preconditioning in globally ischemic rat hearts. Am J Physiol 267:H1403–H1409PubMed

367.

Sbarouni E, Iliodromitis EK, Zoga A, Vlachou G, Andreadou I, Kremastinos DT (2006) The effect of the phytoestrogen genistein on myocardial protection, preconditioning and oxidative stress. Cardiovasc Drugs Ther 20:253–258. https://doi.org/10.1007/s10557-006-8971-6 PubMedCrossRef

368.

Schmidt M, Jacobsen JB, Lash TL, Bøtker HE, Sorensen HT (2012) 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. Br Med J 344:e356. https://doi.org/10.1136/bmj.e356 CrossRef

369.

Schmidt MR, Stottrup NB, Contractor H, Hyldebrandt JA, Johannsen M, Pedersen CM, Birkler R, Ashrafian H, Sorensen KE, Kharbanda RK, Redington AN, Bøtker HE (2014) Remote ischemic preconditioning with—but not without—metabolic support protects the neonatal porcine heart against ischemia-reperfusion injury. Int J Cardiol 170:388–393. https://doi.org/10.1016/j.ijcard.2013.11.020 PubMedCrossRef

370.

Schomig A, Ndrepepa G, Mehilli J, Dirschinger J, Nekolla SG, Schmitt C, Martinoff S, Seyfarth M, Schwaiger M, Kastrati A, investigators S-s (2004) A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol 44:2073–2079. https://doi.org/10.1016/j.jacc.2004.09.043 PubMedCrossRef

371.

Schulz R, Agg B, Ferdinandy P (2017) Survival pathways in cardiac conditioning: individual data vs. meta-analyses. What do we learn? Basic Res Cardiol 113:4. https://doi.org/10.1007/s00395-017-0661-y PubMedCrossRef

372.

Schulz R, Kappeler C, Coenen HH, Backisch A, Heusch G (1996) Positron emission tomography analysis of [1–11C] acetate kinetics in short-term hibernating myocardium. Circulation 94:I-542 (Abstr) CrossRef

373.

Schulz R, Post H, Vahlhaus C, Heusch G (1998) Ischemic preconditioning in pigs: a graded phenomenon. Its relation to adenosine and bradykinin. Circulation 98:1022–1029. https://doi.org/10.1161/01.CIR.98.10.1022 PubMedCrossRef

374.

Schulz R, Rose J, Post H, Heusch G (1995) Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflügers Arch 430:273–282PubMedCrossRef

375.

Schwartz LM, Verbinski SG, Vander Heide RS, Reimer KA (1997) Epicardial temperature is a major predictor of myocardial infarct size in dogs. J Mol Cell Cardiol 29:1577–1583. https://doi.org/10.1006/jmcc.1997.0391 PubMedCrossRef

376.

Schwarz ER, Somoano Y, Hale SL, Kloner RA (2000) What is the required reperfusion period for assessment of myocardial infarct size using triphenyltetrazolium chloride staining in the rat? J Thromb Thrombolysis 10:181–187. https://doi.org/10.1023/A:1018770711705 PubMedCrossRef

377.

Scofield SL, Singh K (2016) Confirmation of myocardial ischemia and reperfusion injury in mice using surface pad electrocardiography. J Vis Exp. https://doi.org/10.3791/54814 PubMedPubMedCentralCrossRef

378.

Selye H, Bajusz E, Grasso S, Mendell P (1960) Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 11:398–407. https://doi.org/10.1177/000331976001100505 PubMedCrossRef

379.

Shao Y, Redfors B, Stahlman M, Tang MS, Miljanovic A, Mollmann H, Troidl C, Szardien S, Hamm C, Nef H, Boren J, Omerovic E (2013) A mouse model reveals an important role for catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy. Eur J Heart Fail 15:9–22. https://doi.org/10.1093/eurjhf/hfs161 PubMedCrossRef

380.

Shen C, Jennings RB (1972) Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol 67:417–440PubMedPubMedCentral

381.

Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, Li J, Gross G, Wilson GJ, Callahan J, Redington AN (2009) Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond) 117:191–200. https://doi.org/10.1042/CS20080523 CrossRef

382.

Shintaku T, Ohba T, Niwa H, Kushikata T, Hirota K, Ono K, Matsuzaki Y, Imaizumi T, Kuwasako K, Sawamura D, Murakami M (2014) Effects of propofol on electrocardiogram measures in mice. J Pharmacol Sci 126:351–358. https://doi.org/10.1254/jphs.14181FP PubMedCrossRef

383.

Siegmund B, Koop A, Klietz T, Schwartz P, Piper HM (1990) Sarcolemmal integrity and metabolic competence of cardiomyocytes under anoxia-reoxygenation. Am J Physiol Heart Circ Physiol 258:H285–H291CrossRef

384.

Skyschally A, Amanakis G, Neuhauser M, Kleinbongard P, Heusch G (2017) Impact of electrical defibrillation on infarct size and no-reflow in pigs subjected to myocardial ischemia-reperfusion without and with ischemic conditioning. Am J Physiol Heart Circ Physiol 313:H871–H878. https://doi.org/10.1152/ajpheart.00293.2017 PubMedCrossRef

385.

Skyschally A, Gent S, Amanakis G, Schulte C, Kleinbongard P, Heusch G (2015) Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways. Circ Res 117:279–288. https://doi.org/10.1161/CIRCRESAHA.117.306878 PubMedCrossRef

386.

Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, Heusch G (2007) Bidirectional role of tumor necrosis factor-α in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 100:140–146. https://doi.org/10.1161/01.RES.0000255031.15793.86 PubMedCrossRef

387.

Skyschally A, Haude M, Dörge H, Thielmann M, Duschin A, van de Sand A, Konietzka I, Büchert A, Aker S, Massoudy P, Schulz R, Erbel R, Heusch G (2004) Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation 109:2337–2342. https://doi.org/10.1161/01.CIR.0000127961.66744.F4 PubMedCrossRef

388.

Skyschally A, Kleinbongard P, Lieder HR, Gedik N, Stoian L, Amanakis G, Elbers E, Heusch G (2018) Humoral transfer and intra-myocardial signal transduction of protection by remote ischemic perconditioning in pigs, rats, and mice. Am J Physiol Heart Circ Physiol 315:H159–H172. https://doi.org/10.1152/ajpheart.00152.2018 PubMedCrossRef

389.

Skyschally A, Rose J, Leischik R, Erbel R, Heusch G (1997) Regionale myokardiale Funktion und Durchblutung nach koronarer Mikroembolisation. Z Kardiol 86(Suppl. 2):253

390.

Skyschally A, Schulz R, Gres P, Konietzka I, Martin C, Haude M, Erbel R, Heusch G (2004) Coronary microembolization does not induce acute preconditioning against infarction in pigs—the role of adenosine. Cardiovasc Res 63:313–322. https://doi.org/10.1016/j.cardiores.2004.04.003 PubMedCrossRef

391.

Skyschally A, Schulz R, Heusch G (2010) Cyclosporine A at reperfusion reduces infarct size in pigs. Cardiovasc Drugs Ther 24:85–87. https://doi.org/10.1007/s10557-010-6219-y PubMedPubMedCentralCrossRef

392.

Skyschally A, Schulz R, Heusch G (1993) Cordat II: a new program for data acquisition and on-line calculation of hemodynamic and regional myocardial dimension parameters. Comput Biol Med 23:359–367PubMedCrossRef

393.

Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, Heusch G (2009) Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 104:469–483. https://doi.org/10.1007/s00395-009-0040-4 PubMedCrossRef

394.

Skyschally A, Walter B, Heusch G (2013) Coronary microembolization during early reperfusion—infarct extension, but protection by ischemic postconditioning. Eur Heart J 34:3314–3321. https://doi.org/10.1093/eurheartj/ehs434 PubMedCrossRef

395.

Skyschally A, Walter B, Schultz HR, Heusch G (2013) The antiarrhythmic dipeptide ZP1609 (danegaptide) when given at reperfusion reduces myocardial infarct size in pigs. Naunyn Schmiedebergs Arch Pharmacol 386:383–391. https://doi.org/10.1007/s00210-013-0840-9 PubMedCrossRef

396.

Sluijter JPG, Davidson SM, Boulanger CM, Buzas EI, de Kleijn DPV, Engel FB, Giricz Z, Hausenloy DJ, Kishore R, Lecour S, Leor J, Madonna R, Perrino C, Prunier F, Sahoo S, Schiffelers RM, Schulz R, Van Laake LW, Ytrehus K, Ferdinandy P (2018) Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position paper from the working group on cellular biology of the heart of the European Society of Cardiology. Cardiovasc Res 114:19–34. https://doi.org/10.1093/cvr/cvx211 PubMedCrossRef

397.

Small BA, Lu Y, Hsu AK, Gross GJ, Gross ER (2015) Morphine reduces myocardial infarct size via heat shock protein 90 in rodents. Biomed Res Int 2015:129612. https://doi.org/10.1155/2015/129612 PubMedPubMedCentralCrossRef

398.

Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, Deanfield JE (1995) Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 74:247–253PubMedPubMedCentralCrossRef

399.

Spahr R, Probst I, Piper HM (1985) Substrate utilization of adult cardiac myocytes. Basic Res Cardiol 80(Suppl 1):53–56PubMed

400.

Srisakuldee W, Makazan Z, Nickel BE, Zhang F, Thliveris JA, Pasumarthi KB, Kardami E (2014) The FGF-2-triggered protection of cardiac subsarcolemmal mitochondria from calcium overload is mitochondrial connexin 43-dependent. Cardiovasc Res 103:72–80. https://doi.org/10.1093/cvr/cvu066 PubMedCrossRef

401.

Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L’Huillier I, Aupetit J-F, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M (2005) Postconditioning the human heart. Circulation 112:2143–2148. https://doi.org/10.1161/CIRCULATIONAHA.105.558122 PubMedCrossRef

402.

Starkov AA (2010) Measurement of mitochondrial ROS production. Methods Mol Biol 648:245–255. https://doi.org/10.1007/978-1-60761-756-3_16 PubMedPubMedCentralCrossRef

403.

Stenslokken KO, Rutkovskiy A, Kaljusto ML, Hafstad AD, Larsen TS, Vaage J (2009) Inadvertent phosphorylation of survival kinases in isolated perfused hearts: a word of caution. Basic Res Cardiol 104:412–423. https://doi.org/10.1007/s00395-009-0780-1 PubMedCrossRef

404.

Sterling DL, Thornton JD, Swafford A, Gottlieb SF, Bishop SP, Stanley AW, Downey JM (1993) Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation 88:1931–1936PubMedCrossRef

405.

Stottrup NB, Lofgren B, Birkler RD, Nielsen JM, Wang L, Caldarone CA, Kristiansen SB, Contractor H, Johannsen M, Bøtker HE, Nielsen TT (2010) Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection. Cardiovasc Res 88:257–266PubMedCrossRef

406.

Strijdom H, Genade S, Lochner A (2004) Nitric oxide synthase (NOS) does not contribute to simulated ischaemic preconditioning in am isolated rat cardiomyocyte model. Cardiovasc Drugs Ther 18:99–112. https://doi.org/10.1023/B:CARD.0000029027.50796.84 PubMedCrossRef

407.

Sturtzel C (2017) Endothelial Cells. Adv Exp Med Biol 1003:71–91. https://doi.org/10.1007/978-3-319-57613-8_4 PubMedCrossRef

408.

Sumeray MS, Yellon DM (1998) Characterisation and validation of a murine model of global ischaemia-reperfusion injury. Mol Cell Biochem 186:61–68PubMedCrossRef

409.

Sutherland FJ, Hearse DJ (2000) The isolated blood and perfusion fluid perfused heart. Pharmacol Res 41:613–627. https://doi.org/10.1006/phrs.1999.0653 PubMedCrossRef

410.

Symons JA, Myles PS (2006) Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 97:127–136. https://doi.org/10.1093/bja/ael149 PubMedCrossRef

411.

Szalai G, Csordas G, Hantash BM, Thomas AP, Hajnoczky G (2000) Calcium signal transmission between ryanodine receptors and mitochondria. J Biol Chem 275:15305–15313PubMedCrossRef

412.

Taegtmeyer H (1994) Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 19:59–113PubMedCrossRef

413.

Taegtmeyer H, Hems R, Krebs HA (1980) Utilization of energy-providing substrates in the isolated working rat heart. Biochem J 186:701–711PubMedPubMedCentralCrossRef

414.

Takuma S, Suehiro K, Cardinale C, Hozumi T, Yano H, Shimizu J, Mullis-Jansson S, Sciacca R, Wang J, Burkhoff D, Di Tullio MR, Homma S (2001) Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach. Am J Physiol Heart Circ Physiol 280:H2364–H2370. https://doi.org/10.1152/ajpheart.2001.280.5.H2364 PubMedCrossRef

415.

Tan MY, Xia B, Xiao Z, Fan ZW, Zhou H, Guo X, Huang YC (2017) Development of a new model for acute myocardial infarction in rabbits. J Vet Med Sci 79:467–473. https://doi.org/10.1292/jvms.16-0114 PubMedPubMedCentralCrossRef

416.

Ter Horst EN, Krijnen PAJ, Flecknell P, Meyer KW, Kramer K, van der Laan AM, Piek JJ, Niessen HWM (2017) Sufentanil-medetomidine anaesthesia compared with fentanyl/fluanisone-midazolam is associated with fewer ventricular arrhythmias and death during experimental myocardial infarction in rats and limits infarct size following reperfusion. Lab Anim. https://doi.org/10.1177/0023677217724485 PubMedPubMedCentralCrossRef

417.

Ternant D, Ivanes F, Prunier F, Mewton N, Bejan-Angoulvant T, Paintaud G, Ovize M, Angoulvant D (2017) Revisiting myocardial necrosis biomarkers: assessment of the effect of conditioning therapies on infarct size by kinetic modelling. Sci Rep 7:10709. https://doi.org/10.1038/s41598-017-11352-4 PubMedPubMedCentralCrossRef

418.

Theroux P, Franklin D, Ross J Jr, Kemper WS (1974) Regional myocardial function during acute coronary artery occlusion and its modification by pharmacological agents in the dog. Circ Res 35:896–908PubMedCrossRef

419.

Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, Andre-Fouet X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M (2008) Long-term benefit of postconditioning. Circulation 117:1037–1044. https://doi.org/10.1161/CIRCULATIONAHA.107.729780 PubMedCrossRef

420.

Thielmann M, Kottenberg E, Boengler K, Raffelsieper C, Neuhäuser M, Peters J, Jakob H, Heusch G (2010) Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol 105:657–664. https://doi.org/10.1007/s00395-010-0104-5 PubMedCrossRef

421.

Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuhäuser M, Peters J, Jakob H, Heusch G (2013) Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 382:597–604. https://doi.org/10.1016/S0140-6736(13)61450-6 PubMedCrossRef

422.

Thielmann M, Sharma V, Al-Attar N, Bulluck H, Bisleri G, Jh Bunge J, Czerny M, Ferdinandy P, Frey UH, Heusch G, Holfeld J, Kleinbongard P, Kunst G, Lang I, Lentini S, Madonna R, Meybohm P, Muneretto C, Obadia JF, Perrino C, Prunier F, Sluijter JPG, Van Laake LW, Sousa-Uva M, Hausenloy DJ (2017) ESC joint working groups on cardiovascular surgery and the cellular biology of the heart position paper: perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery. Eur Heart J 38:2392–2407. https://doi.org/10.1093/eurheartj/ehx383 PubMedPubMedCentralCrossRef

423.

Thuny F, Lairez O, Roubille F, Mewton N, Rioufol G, Sportouch C, Sanchez I, Bergerot C, Thibault H, Cung TT, Finet G, Argaud L, Revel D, Derumeaux G, Bonnefoy-Cudraz E, Elbaz M, Piot C, Ovize M, Croisille P (2012) Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 59:2175–2181. https://doi.org/10.1016/j.jacc.2012.03.026 PubMedCrossRef

424.

Tissier R, Ghaleh B, Cohen MV, Downey JM, Berdeaux A (2012) Myocardial protection with mild hypothermia. Cardiovasc Res 94:217–225. https://doi.org/10.1093/cvr/cvr315 PubMedCrossRef

425.

Tran HS, Puc MM, Tran JL, Del Rossi AJ, Hewitt CW (2001) A method of endoscopic endotracheal intubation in rabbits. Lab Anim 35:249–252. https://doi.org/10.1258/0023677011911705 PubMedCrossRef

426.

Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM (2004) Postconditioning: a form of “Modified Reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95:230–232. https://doi.org/10.1161/01.RES.0000138303.76488.fe PubMedCrossRef

427.

Tsovolas K, Iliodromitis EK, Andreadou I, Zoga A, Demopoulou M, Iliodromitis KE, Manolaki T, Markantonis SL, Kremastinos DT (2008) Acute administration of vitamin C abrogates protection from ischemic preconditioning in rabbits. Pharmacol Res 57:283–289. https://doi.org/10.1016/j.phrs.2008.02.003 PubMedCrossRef

428.

Tukey JW (1977) Exploratory data analysis (1977). 1st edition, Addison-Wesley, Reading

429.

Ungi I, Ungi T, Ruzsa Z, Nagy E, Zimmermann Z, Csont T, Ferdinandy P (2005) Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty. Chest 128:1623–1628. https://doi.org/10.1378/chest.128.3.1623 PubMedCrossRef

430.

van Veen TAB, van Rijen HVM, Opthof T (2001) Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res 51:217–229PubMedCrossRef

431.

Vander Heide RS, Rim D, Hohl CM, Ganote CE (1990) An in vitro model of myocardial ischemia utilizing isolated adult rat myocytes. J Mol Cell Cardiol 22:165–181PubMedCrossRef

432.

Varga ZV, Giricz Z, Bencsik P, Madonna R, Gyongyosi M, Schulz R, Mayr M, Thum T, Puskas LG, Ferdinandy P (2015) Functional genomics of cardioprotection by ischemic conditioning and the influence of comorbid conditions: implications in target identification. Curr Drug Targets 16:904–911. https://doi.org/10.2174/1389450116666150427154203 PubMedCrossRef

433.

Varga ZV, Zvara A, Farago N, Kocsis GF, Pipicz M, Gaspar R, Bencsik P, Gorbe A, Csonka C, Puskas LG, Thum T, Csont T, Ferdinandy P (2014) MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs. Am J Physiol Heart Circ Physiol 307:H216–H227. https://doi.org/10.1152/ajpheart.00812.2013 PubMedCrossRef

434.

go back to reference Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, Zhu X (2001) The sequence of the human genome. Science 291:1304–1351. https://doi.org/10.1126/science.1058040 PubMedCrossRef Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, Zhu X (2001) The sequence of the human genome. Science 291:1304–1351. https://doi.org/10.1126/science.1058040 PubMedCrossRef

435.

Vidavalur R, Swarnakar S, Thirunavukkarasu M, Samuel SM, Maulik N (2008) Ex vivo and in vivo approaches to study mechanisms of cardioprotection targeting ischemia/reperfusion (i/r) injury: useful techniques for cardiovascular drug discovery. Curr Drug Discov Technol 5:269–278PubMedCrossRef

436.

Vietta GG, Andrades ME, Dall’alba R, Schneider SI, Frick LM, Matte U, Biolo A, Rohde LE, Clausell N (2013) Early use of cardiac troponin-I and echocardiography imaging for prediction of myocardial infarction size in Wistar rats. Life Sci 93:139–144. https://doi.org/10.1016/j.lfs.2013.05.026 PubMedCrossRef

437.

Vinegoni C, Aguirre AD, Lee S, Weissleder R (2015) Imaging the beating heart in the mouse using intravital microscopy techniques. Nat Protoc 10:1802–1819. https://doi.org/10.1038/nprot.2015.119 PubMedPubMedCentralCrossRef

438.

Virag JA, Lust RM (2011) Coronary artery ligation and intramyocardial injection in a murine model of infarction. J Vis Exp. https://doi.org/10.3791/2581 PubMedPubMedCentralCrossRef

439.

Vivaldi MT, Kloner RA, Schoen FJ (1985) Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol 121:522–530PubMedPubMedCentral

440.

Walker DM, Walker JM, Pugsley WB, Pattinson CW, Yellon DM (1995) Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 27:1349–1357PubMedCrossRef

441.

Wayman NS, McDonald MC, Chatterjee PK, Thiemermann C (2003) Models of coronary artery occlusion and reperfusion for the discovery of novel antiischemic and antiinflammatory drugs for the heart. Methods Mol Biol 225:199–208. https://doi.org/10.1385/1-59259-374-7:199 PubMedCrossRef

442.

Whelan RS, Kaplinskiy V, Kitsis RN (2010) Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 72:19–44. https://doi.org/10.1146/annurev.physiol.010908.163111 PubMedCrossRef

443.

Wilder CD, Masoud R, Yazar D, O’Brien BA, Eykyn TR, Curtis MJ (2016) Contractile function assessment by intraventricular balloon alters the ability of regional ischaemia to evoke ventricular fibrillation. Br J Pharmacol 173:39–52. https://doi.org/10.1111/bph.13332 PubMedCrossRef

444.

Wu H, Li L, Niu P, Huang X, Liu J, Zhang F, Shen W, Tan W, Wu Y, Huo Y (2017) The Structure-function remodeling in rabbit hearts of myocardial infarction. Physiol Rep 5:e13311. https://doi.org/10.14814/phy2.13311 PubMedPubMedCentralCrossRef

445.

Wu W, Teixeira LR, Light RW (1998) Doxycycline pleurodesis in rabbits: comparison of results with and without chest tube. Chest 114:563–568PubMedCrossRef

446.

Wu Y, Yin X, Wijaya C, Huang MH, McConnell BK (2011) Acute myocardial infarction in rats. J Vis Exp. https://doi.org/10.3791/2464 CrossRefPubMedPubMedCentral

447.

Xu Q, Ming Z, Dart AM, Du XJ (2007) Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin Exp Pharmacol Physiol 34:499–507. https://doi.org/10.1111/j.1440-1681.2007.04601.x PubMedCrossRef

448.

Yang XM, Cui L, Alhammouri A, Downey JM, Cohen MV (2013) Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart. Cardiovasc Drugs Ther 27:403–412. https://doi.org/10.1007/s10557-013-6474-9 PubMedCrossRef

449.

Yang XM, Liu Y, Cui L, Yang X, Liu Y, Tandon N, Kambayashi J, Downey JM, Cohen MV (2013) Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts. Cardiovasc Drugs Ther 27:109–115. https://doi.org/10.1007/s10557-012-6436-7 PubMedCrossRef

450.

Yang XM, Liu Y, Cui L, Yang X, Liu Y, Tandon N, Kambayashi J, Downey JM, Cohen MV (2012) Platelet P2Y12 blockers confer direct postconditioning-like protection in reperfused rabbit hearts. J Cardiovasc Pharmacol Ther 18:251–262. https://doi.org/10.1177/1074248412467692 PubMedPubMedCentralCrossRef

451.

Yang XP, Liu YH, Rhaleb NE, Kurihara N, Kim HE, Carretero OA (1999) Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am J Physiol 277:H1967–H1974PubMedCrossRef

452.

Yetgin T, Uitterdijk A, Te Lintel Hekkert M, Merkus D, Krabbendam-Peters I, van Beusekom HM, Falotico R, Serruys PW, Manintveld OC, van Geuns RJ, Zijlstra F, Duncker DJ (2015) Limitation of infarct size and no-reflow by intracoronary adenosine depends critically on dose and duration. J Am Coll Cardiol Cardiovasc Interv 8:1990–1999. https://doi.org/10.1016/j.jcin.2015.08.033 CrossRef

453.

Zaja I, Bai X, Liu Y, Kikuchi C, Dosenovic S, Yan Y, Canfield SG, Bosnjak ZJ (2014) Cdk1, PKCdelta and calcineurin-mediated Drp1 pathway contributes to mitochondrial fission-induced cardiomyocyte death. Biochem Biophys Res Commun 453:710–721. https://doi.org/10.1016/j.bbrc.2014.09.144 PubMedPubMedCentralCrossRef

454.

Zangrillo A, Musu M, Greco T, Di Prima AL, Matteazzi A, Testa V, Nardelli P, Febres D, Monaco F, Calabro MG, Ma J, Finco G, Landoni G (2015) Additive effect on survival of anaesthetic cardiac protection and remote ischemic preconditioning in cardiac surgery: a Bayesian network meta-analysis of randomized trials. PLoS One 10:e0134264. https://doi.org/10.1371/journal.pone.0134264 PubMedPubMedCentralCrossRef

455.

Zaugg M, Lucchinetti E, Behmanesh S, Clanachan AS (2014) Anesthetic cardioprotection in clinical practice from proof-of-concept to clinical applications. Curr Pharm Des 20:5706–5726. https://doi.org/10.2174/1381612820666140204120829 PubMedCrossRef

456.

Zhai P, Eurell TE, Cotthaus R, Jeffery EH, Bahr JM, Gross DR (2000) Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol 279:H2766–H2775. https://doi.org/10.1152/ajpheart.2000.279.6.H2766 PubMedCrossRef

457.

Zhang H, Goodman HM, Jansson S (1997) Antisense inhibition of the photosystem I antenna protein Lhca4 in Arabidopsis thaliana. Plant Physiol 115:1525–1531PubMedPubMedCentralCrossRef

458.

Zhang LZ, Guo Z (2009) Tramadol reduces myocardial infarct size and expression and activation of nuclear factor kappa B in acute myocardial infarction in rats. Eur J Anaesthesiol 26:1048–1055. https://doi.org/10.1097/EJA.0b013e32832c785d PubMedCrossRef

459.

Zhao B, Summers FA, Mason RP (2012) Photooxidation of Amplex Red to resorufin: implications of exposing the Amplex Red assay to light. Free Radic Biol Med 53:1080–1087. https://doi.org/10.1016/j.freeradbiomed.2012.06.034 PubMedPubMedCentralCrossRef

460.

Zhao Z-Q, Corvera JS, Halkos ME, Kerendi F, Wang N-P, Guyton RA, Vinten-Johansen J (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285:H579–H588. https://doi.org/10.1152/ajpheart.01069.2002 PubMedCrossRef

461.

Zhou K, Yang B, Zhou XM, Tan CM, Zhao Y, Huang C, Liao XB, Xiao HB (2007) Effects of remote ischemic preconditioning on the flow pattern of the left anterior descending coronary artery in normal subjects. Int J Cardiol 122:250–251PubMedCrossRef

462.

Zhu A, Wei X, Zhang Y, You T, Yao S, Yuan S, Xu H, Li F, Mao W (2017) Propofol provides cardiac protection by suppressing the proteasome degradation of caveolin-3 in ischemic/reperfused rat hearts. J Cardiovasc Pharmacol 69:170–177. https://doi.org/10.1097/FJC.0000000000000454 PubMedCrossRef

463.

Zielonka J, Kalyanaraman B (2010) Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic Biol Med 48:983–1001. https://doi.org/10.1016/j.freeradbiomed.2010.01.028 PubMedPubMedCentralCrossRef

464.

Zornoff LA, Paiva SA, Minicucci MF, Spadaro J (2009) Experimental myocardium infarction in rats: analysis of the model. Arq Bras Cardiol 93(434–40):426–432

465.

Zuurbier CJ, Emons VM, Ince C (2002) Hemodynamics of anesthetized ventilated mouse models: aspects of anesthetics, fluid support, and strain. Am J Physiol Heart Circ Physiol 282:H2099–H2105. https://doi.org/10.1152/ajpheart.01002.2001 PubMedCrossRef

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2018

Rat atrial engineered heart tissue: a new in vitro model to study atrial biology

LXR/RXR signaling and neutrophil phenotype following myocardial infarction classify sex differences in remodeling

Local metabolic hypothesis is not sufficient to explain coronary autoregulatory behavior

Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target

Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction